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ABSTRACT 
 
Statement of Problem: Opioid epidemic in United States has been, in part, linked to 
prescribing practices of practitioners who treat chronic pain. The increase in morbidity and 
mortality associated with widespread prescription of opioid pain relievers (OPRs) has been the 
driving force in the reassessment of clinical prescribing guidelines. Given the enormity and 
urgency of the problem, in 2016, the Centers for Disease Control and Prevention (CDC) 
introduced guidelines for prescribing opioids to chronic noncancer pain to primary care 
practitioners. The introduction of the clinical guidelines sparked much concerns from providers 
and activist groups. There is little known in the literature relating to providers’ knowledge, 
belief, attitudes relating to practices that utilize the 2016 CDC opioid guidelines for chronic pain. 
Therefore, the purpose of this study was to explore and understand the relationships among 
providers’ (physician, nurse practitioner and physician assistant) knowledge, belief, attitudes, 
and practices regarding 2016 CDC opioid prescribing guidelines, A secondary aim of the study 
was identifying the presence of mediating variable between knowledge and practice.  
Theories: The constructs addressed in the study are knowledge, belief, attitude, 
innovation, and practice adherence. The study is built upon a novel framework created by the 
researcher based on well-established works of Diffusion of Innovation Theory (DOI) by E. M. 
Rogers and Knowledge-Attitude-Practice (KAP) model. Integrated elements of both theories are 
supporting pillars of the study. 
Methods: The design was descriptive, cross-sectional, and correlational utilizing 
previously published quantitative survey tool (McCalmont et al., 2018). The sample consisted of 
243 practitioners of 47 Physicians, 57 Physician Assistants and 55 Nurse Practitioners. A letter 
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of solicitation was emailed through national professional organizations of American Academy of 
Nurse Practitioners (AANP) and American Academy of Physician Assistants (AAPA). 
Results:  Survey respondents demonstrated varied knowledge recall of the 2016 opioid 
prescribing guidelines. Knowledge was a statistically significant predictor of belief variable 
(r= .294, p < 0.001). A statistically significant bivariate relationship emerged between belief and 
individual attitude (r = .831, p < 0.001). Aligned with an increase on the belief scale, a provider’s 
individual attitude scale score increased regarding implementation of the guidelines to improve 
patient outcomes. Knowledge was a significant predictor of the Belief Scale,                                     
Beta = .16, p = 0.002. As the knowledge variable increased, the belief variable also increased. 
Knowledge was a significant predictor of the Individual Attitude Scale, Beta = .26, p < 0.001. As 
knowledge increased, scores on the individual Attitude Scale increased. Knowledge did not 
directly predict either of the practice variables (Practice Scale I or Practice Scale II). 
Belief was a statistically significant predictor of Practice Scale I (harm reduction), Beta = 
0.47, p < 0.001. As a provider’s belief increased, their Practice Scale (harm reduction) increased. 
However, belief was not a predictor for Practice Scale II (using nonopioid modalities). Individual 
attitude was a significant predictor of harm reduction, Beta = 0.20, p = 0.008. As individual 
attitude increased, practicing attitudes of harm reduction also increased. 
Individual attitude was a significant predictor of Practice Scale in using nonopioid modalities, 
Beta = 0.56, p < 0.001. As individual attitude increased, a provider’s practice of using nonopioid 
modalities also increased. The study concludes knowledge effects were completely mediated 
through individual attitude and belief. 
Conclusion:  Complexity of pain requires multidisciplinary approach to management. 
Multidisciplinary practitioners include providers from nursing, physician assistant and medical 
vi 
colleagues. All these practitioners have varied training philosophies and they share a common 
practice of managing patients with chronic pain in the primary care arena.  
Perceptions influence practices and thus further understanding of perceptions will better steer 
practitioner guidance. Subjective construct of belief and attitude are interrelated, and they are 
significant drivers of professional autonomous practice. This study signals that subjective 
variable of belief and attitude have mediating effect and influence on acceptance and 
implementation of guidelines and thus exploring subjective constructs through qualitative 
methods may further illuminate participant characteristics, as barriers to guideline adoption. 
 
Keywords and phrases: CDC Guideline, opioid epidemic, primary care management, guideline 
adherence. 
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CHAPTER I 
INTRODUCTION 
Background of the Problem 
Chronic pain is a common complaint in primary care, and it is the top cause of disability 
in the United States (Clark, 2002; Smith, Hopton, & Chambers, 1999). Primary care practitioners 
treat nearly half of all chronic-pain patients through various modalities, including prescriptive 
opioids (Clark, 2002). The pivotal event that spurred liberal opioid prescribing practices for pain 
management started with the notion that narcotics rarely lead to addiction (Porter & Jick, 1980). 
For decades that followed, health care providers, legislators and the pharmaceutical industry 
cited this study for encouragement to treat pain with opioids. Since then, the use of opioid pain 
reliever (OPR) for treatment of chronic pain in the United States has escalated dramatically and 
beyond containment (Jones, 2013). Some common OPRs include hydrocodone and oxycodone; 
hydrocodone usage has doubled, and consumption of oxycodone has increased by 500% (Jones, 
2013). The overprescribing of OPRs has led to a concurrent increase in opioid misuse and 
addiction, closely followed by an increase in opioid-related overdose fatalities (Dart et al., 2015). 
The National Survey on Drug Use and Health (Hughes et al., 2016) concluded that 
among individuals over 12 years of age, an estimated 97.5 million individuals (36.4% of the 
population) used prescription opioids, and 12.5 million (4.7% of the population) misused 
prescription opioids (Hughes et al., 2016). The increase in morbidity and mortality associated 
with widespread prescription of OPRs has been the driving force in reassessment of clinical 
prescribing guidelines. Given the enormity and urgency of the problem, in 2014, the Centers for 
Disease Control and Prevention (CDC) added opioid-overdose prevention to the priority list of 
the top five public health challenges (CDC, 2014). 
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Approximately one third of primary care practitioners encounter chronic pain patients in 
their practices (Gureje et al., 1998). Practitioners are overwhelmed and challenged to manage 
chronic noncancer pain (CNCP) and lack access to pain consultants who offer comprehensive 
pain care (Alford, 2016). Furthermore, the United States houses only 4,000 specialists certified 
in pain management (Breuer et al., 2007). As a result of the limited number of pain specialists, 
primary care providers treat most patients with chronic pain in the United States. 
While primary care providers treat most of the chronic pain patients, they are challenged 
with having little formal training in pain management and minimal guidance for best opioid 
prescribing practices (Jamison et al., 2014). In 2016, the CDC released opioid prescribing 
guidelines for CNCP, aimed to alert primary care practitioners and other primary health care 
providers to the use of pharmaceutical management in treating chronic pain lasting longer than 3 
months, excluding cancer pain and end-of-life pain care (Dowell et al., 2016). The intended 
purpose of the 2016 CDC Guideline is to promote safe prescribing practices among primary care 
providers while decreasing mortality associated with opioid-use disorder, thereby decreasing 
subsequent deaths from opioid-related overdoses. The well-intentioned recommendations have 
created some concern about the lack of user-friendliness and insufficiency in meeting the needs 
of both patients and providers. 
Statement of the Problem 
It is evident that opioid related deaths have become a personal tragedy and an economic 
burden to society. Attempts to rein the crisis through public initiatives have not shown an 
impactful and measured solution. Legislative initiatives have laid the foundations for 
accountability for health care providers and clinical guidelines have been released to provide 
direction for prescribing practices. However, practitioners are resistant to easily adopting 
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guidelines. The CDC 2016 guidelines relating to opioid prescribing has led to much outcry and 
controversy for its prescriptive direction rather than suggestive guidance.  
Need for the Study 
Primary care practitioners are responsible for prescribing and treating most of chronic 
pain patients utilizing all types of modalities including opioids. The primary care practitioners 
have varied training backgrounds and experiences which may influence their treatment approach 
and treatment philosophy. Therefore, further investigation of primary care providers’ perceptions 
of the value and effectiveness of these guidelines is warranted. 
Purpose of the Study  
The purpose of this study was to investigate primary care providers’ knowledge, belief, 
attitude, and practices of the 2016 CDC opioid prescribing guidelines relating to CNCP. Both 
practitioners and prescribers caring for chronic-pain patients have a critical need to be aware and 
understand the CDC Guideline and individual state mandates to best serve the chronic-pain 
population safely and knowledgeably. To gain insight into healthcare providers' perceptions 
related to the 2016 CDC Opioid Prescribing Guideline through knowledge, beliefs, attitudes 
paradigm and its impact on practice will be useful in practically guiding policy makers to tailor 
guidelines for greater adoption and adherence to the intended practitioner. 
Theoretical Framework  
The theoretical framework of this study is established by integrating two models, 
Knowledge-Attitude-Practice (KAP) model and Roger’s Diffusion of Innovation Theory. The 
constructs in E.M Roger’s Diffusion of Innovation Model, include innovation, communication, 
and time while the constructs of KAP Model explain a linear relationship through three 
constructs of knowledge, attitude, and practice. Combining elements of both frameworks and 
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appreciating complexity of guideline adherence, a novel framework was created to include 
elements of both frameworks discussed. 
Research Questions and Hypotheses 
To understand knowledge, attitudes, and practices regarding the adoption of CDC 
Guidelines of 2016 opioid prescribing by primary care practitioners. A quantitative analysis was 
chosen to investigate the proposed research questions.  
RQ1. What is the relationship between the amount of provider’s post licensure training 
relating to the area of chronic pain management (CPM) and: 
a. The provider’s knowledge of the 2016 CDC Guideline. 
b. The provider’s belief that that the 2016 CDC Guideline will reduce the epidemic 
opioid crisis. 
c. The provider’s belief that the implementation of the 2016 CDC Guideline will 
produce improved outcomes in CPM. 
 HA1a: A statistically significant relationship exists between provider’s post 
licensure training and the provider’s knowledge of the 2016 CDC Guideline.  
 HA1b: A statistically significant relationship exists between provider’s post 
licensure training and the provider’s belief that that the 2016 CDC Guideline will reduce the 
epidemic opioid crisis. 
 HA1c: A statistically significant relationship exists between provider’s post 
licensure training and the provider’s belief that the implementation of the 2016 CDC Guideline 
will produce improved outcomes in CPM. 
 RQ2. What is the relationship between the amount of provider’s years’ experience and: 
a. The provider’s knowledge of the 2016 CDC Guideline. 
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b. The provider’s belief that that the 2016 CDC Guideline will reduce the epidemic 
opioid crisis. 
c. The provider’s belief that the implementation of the 2016 CDC Guideline will 
produce improved outcomes in CPM. 
 HA2a: A statistically significant relationship exists between provider’s years’ 
experience and the provider’s knowledge of the 2016 CDC Guideline.  
 HA2b: A statistically significant relationship exists between provider’s years’ 
experience and the provider’s belief that that the 2016 CDC Guideline will reduce the epidemic 
opioid crisis. 
 HA2c: A statistically significant relationship exists between provider’s years’ 
experience and the provider’s belief that the implementation of the 2016 CDC Guideline will 
produce improved outcomes in CPM. 
RQ3. What is the relationship between the provider’s knowledge of the most current 
CDC Guideline and: 
a. The provider’s belief that that the newest CDC Guideline will reduce the 
epidemic opioid crisis in relation to CPM. 
b. The provider’s belief that the implementation of the most current CDC Guideline 
will produce improved outcomes in CPM. 
 HA3a: A statistically significant relationship exists between provider’s 
knowledge of the most current CDC Guideline and the provider’s belief that that the newest 
CDC Guideline will reduce the epidemic opioid crisis in relation to CPM. 
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 HA3b: A statistically significant relationship exists between provider’s 
knowledge of the most current CDC Guideline and the provider’s belief that the implementation 
of the most current CDC Guideline will produce improved outcomes in CPM. 
RQ4.What is the relationship between the provider’s belief that the CDC Guideline will 
reduce the epidemic opioid crisis in relation to CPM and the provider’s belief that the 
implementation of the CDC Guideline will produce improved outcomes with regard to CPM? 
 HA4: A statistically significant relationship exists between belief that the CDC 
Guideline will reduce the epidemic opioid crisis in relation to CPM and the provider’s belief that 
the implementation of the CDC Guideline will produce improved outcomes about CPM. 
RQ5. Do either of following variables act as mediators between the provider’s 
knowledge of the 2016 CDC Guideline and the provider’s attitude regarding the implementation 
of the 2016 CDC Guideline recommendations in his or her own practice? 
a. The provider’s belief that the 2016 CDC Guideline will reduce the epidemic 
opioid crisis in relation to CPM. 
b. The provider’s belief that the implementation of the 2016 CDC Guideline will 
produce improved patient outcomes in CPM. 
HA5a:   The provider’s belief that the 2016 CDC Guideline will reduce the epidemic 
opioid crisis in CPM acts as a mediator between the provider’s knowledge of the 2016 CDC 
Guideline and the provider’s attitude regarding the implementation of the 2016 CDC Guideline 
in his or her own practice. 
HA5b:  The provider’s belief that the implementation of the 2016 CDC Guideline will 
produce improved patient outcomes with CPM acts as a mediator between the provider’s 
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knowledge of the 2016 CDC Guideline and the provider’s attitude regarding the implementation 
of the 2016 CDC Guideline  in his or her own practice. 
Methodology 
  The methodology for this study was quantitative analysis incorporating 
exploratory, cross sectional and correlational components. Additionally, the inferential statistics 
was utilized, which included multiple regression computation as well as a more comprehensive 
structural equation model with path diagram to identify presence of mediating variables. 
Results 
 The respondents surveyed demonstrated varied recall of the 2016 CDC opioid 
prescribing guidelines. The study also found knowledge was a statistically significant predictor 
of belief variable. However, knowledge alone was not significant predictor of practice. 
Belief   that the newest CDC Guideline will reduce the epidemic opioid crisis in relation 
to CPM was found to be significant predictor practice efforts towards adapting practices to 
further impact harm reduction. Individual attitudes were a significant predictor of practice of 
harm reduction and practice of utilizing non opioid modalities. 
This study results suggest that subjective variable of belief and attitude has a mediating 
effect and influence on acceptance and implementation of guidelines and thus exploring 
subjective constructs through qualitative methods may further illuminate participant 
characteristics, as barriers to guideline adoption. 
Significance 
 The results of the study are integral in understanding healthcare providers' perceptions of 
the 2016 CDC opioid prescribing guidelines relating to the betterment of current opioid crisis. 
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The study measures practitioners’ knowledge of the guidelines and associated beliefs, attitudes 
paradigm and its impact on practice individual clinical practice. Understanding of beliefs and 
attitudes of practitioners is significant in practically guiding policy makers to tailor guidelines for 
greater adoption and adherence to the intended practitioner.
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CHAPTER II 
REVIEW OF LITERATURE 
The Clinical Problem-Pain 
One of the most common ailments that causes an individual to seek medical attention is 
persistent, chronic pain (Gureje et al., 1998). The United States has more 116 million chronic-
pain patients, exceeding other chronic conditions such as heart disease, cancer, and diabetes 
(Dzau & Pizzo, 2014; Institute of Medicine [IOM], 2011; Simon, 2012; Steglitz et al., 2012). 
More than 30% of Americans experience some form of chronic pain; among the rapidly aging 
population, the presence of chronic pain exceeds 40% of the population (Simon, 2012). The 
International Association for the Study of Pain (IASP, 1994) defined pain as an “unpleasant 
sensory and emotional experience associated with actual or potential tissue damage” (p. 210). 
According to IASP (1994), pain has strong cultural, religious, and psychological components 
that alter an individual’s perception and experience. The definition from IASP emphasizes that 
pain is chiefly a subjective experience. Pain can be acute, related to cancer, or CNCP (IASP, 
1994). Chronic-pain conditions can originate from acute pain, recognized as pain that extends 
beyond the period of healing (Simon, 2012). One example is failed back-surgery syndrome, 
which reflects on a constellation of symptoms that result in persistent back pain following one or 
more spine surgeries (North et al., 1991). CNCP can also present insidiously and transition into a 
more prolonged state of unwellness stemming from common conditions such as physical injury, 
degenerative musculoskeletal changes of arthritis, fibromyalgia, migraines, shingles, and 
neuropathic conditions (Simon, 2012). The last qualifier for CNCP is any pain condition that is 
prolonged without relief for a period greater than 3 months (CDC, 2016). 
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The debilitating nature of CNCP can be progressively incapacitating when it interferes 
with daily functionality, the ability to work, sleep patterns, social activities, family relationships, 
and the ability to perform basic common tasks (Brennan, 2015). Additionally, the complexity of 
chronic pain also extends into the psychological realm, where 40 to 50% of patients experiencing 
chronic pain also experience some degree of anxiety and depressive disorder (Banks & Kerns, 
1996). According to the American Pain Society, CNCP is the leading cause of disability and 
impacts 16,128 Americans. CNCP has shown to have a devastating effect on a person’s ability to 
work, function, and participate in society (Chou et al., 2009). 
Gaskin and Richard (2012) analyzed Medical Expenditure Panel Survey (MEPS)  data 
from 2008 to 2010 and determined that health-related costs due to chronic pain reached as high 
as $261–$300 billion annually, with an additional loss of value from lost productivity ranging 
from $299 to $335 billion. Based on these data, pain carries a high burden in health care 
expenditures, disability compensation, lost productivity, lack of employment, and potential loss 
of quality of life. The impact of financial strain on the health care system and human suffering 
created an urgency to alleviate this pervasive health problem. 
Kirson et al. (2017) studied economic burden on insurers using claims from large 
commercially insured data banks containing a population sample of more than 18 million 
beneficiaries. The authors compared the cost of treatment for two mutually exclusive groups of 
opioid abusers and opioid nonabusers. The health care costs of opioid abusers yielded higher 
resource use with an additional $14,810 per patient on an annual basis. However, the increase in 
costs for these patients began 5 months prior to a formal diagnosis of opioid abuse, with 
treatment for alcohol and other polysubstance abuse that predated the opioid-abuse diagnosis.  
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Over the past 20 years, professional organizations and governmental health agencies 
supported medical professionals, encouraging the use of opioids as part of their armamentarium 
to manage pain conditions (Desbiens et al., 1996; Porter & Jick, 1980). Policymakers and 
authoritative agencies championed better treatment and management of undertreated pain 
through promotional campaigns such as “Decade of Pain Control and Research” (Brennan et al., 
2016) and pain relief as “a human right” (Baker, 2017, p. 215). The Joint Commission on 
Accreditation of Healthcare Organizations (JCAHO) and the American Pain Society (APS) 
consensus statement on undertreated pain was the impetus for the development and nationwide 
initiative called “Pain as the 5th Vital Sign,” which required use of a patient reported numeric 
pain rating scale for all clinical encounters (Berry & Dahl, 2000; Kirsch et al., 2000). This 
mandatory objective measure of pain was an expected inquiry, upon every patient encounter. 
This may have inadvertently steered practitioners to prescribe an easily accessible 
pharmaceutical to relieve the symptom of pain and thereby resolve the pain concern of the 
patient. 
Societal Problem-Opioids 
In response to the demand from the medical community and urgency to treat pain and 
suffering, the pharmaceutical industry and market forces increased production of newer 
formulations of opioids with higher degrees of potency and extended half-lives (Rowbotham et 
al., 2003; Van Zee, 2009). Moreover, prescribers followed in tandem, treating the suffering and 
undertreatment of pain with now easily accessible narcotics, thereby decreasing the cost of 
unrelieved pain to individuals and society. The realization of decreased pain (despite the choice 
of treatment) helped patients feel better and return to more productive life. (Kirson et al., 2017). 
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As the production of opioids increased to meet the treatment demand for chronic pain, the 
National Vital Statistics System (NVSS) noted that the trajectory of opioid prescriptions for 
CNCP treatment had increased dramatically since 2011 (CDC, 2015b; Hedegaard & Miniño 
2017; Manchikanti et al., 2012). This increased prescriptive availability of opioids also paralleled 
an increase in opioid misuse, with a growing prevalence of abuse, diversion, and mortality 
(CDC, 2015a; U.S. Department of Health and Human Services, 2016). Between 2000 and 2014, 
opioid-related overdose deaths increased by 137% (Rudd et al., 2016). Nearly 2.1 million people 
have misused prescription opioids for the first time (Murphy et al., 2018). According to U.S. 
Department of Health and Human Services (2016), 63,600 deaths involved drug overdoses, 
which translates to approximately 89 deaths per day (Hedegaard & Miniño, 2017 Seth et al., 
2018). Of those deaths, 66.4% (42,249) were opioid-related and 32,445 were prescription-related 
opioid mortalities (Hughes et al., 2016; Seth et al., 2016). Clearly, prescription opioids are 
heavily used to treat CNCP. 
In 2013, medical personnel dispensed an astonishing 207 million prescriptions in the 
United States (Volkow et al., 2014). The 2015 National Survey on Drug Use and Health 
discovered that approximately 12.5 million people, age 12 and older, misused prescription pain 
relievers (Hughes et al., 2016). The Council of Economic Advisors estimated the economic 
burden of the opioid epidemic at $504.0 billion in 2015, reaching 2.8% of the gross domestic 
product for that year (Council of Economic Advisors, 2018). 
On the regional front, according to the National Institute of Drug Abuse (2016), New 
Jersey alone had 1,409 opioid-related overdose deaths, accounting for 16 deaths per 100,000 
people. This statistic places New Jersey higher than the national average category, which is 13.3 
deaths per 100,000 (National Institute of Drug Abuse, 2016). Furthermore, the Institute 
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determined the largest increase in deaths occurred from heroin, with 97 deaths in 2010; heroin 
deaths rose to 850 by 2016. In view of this public health crisis, deaths from prescription synthetic 
opioids have also risen from 35 to 689 deaths in the same period of 2010 to 2016 (National 
Institute of Drug Abuse, 2016). To show the connection between usage and availability, 
prescription data from IMS (2016) Health National Prescription Audit revealed that New Jersey 
healthcare providers wrote 55 opioid prescriptions per 100 people, accounting for 4.9 million 
prescriptions in a single year. Thus, the opioid drug problem has reached a magnitude of crisis 
proportions in the United States. The escalation of the negative impact has once again captured 
the attention of government agencies, medical organizations, legislators, and the public. Now, 
the urgency to curtail this matter has escalated to the highest priority level by all. In particular, 
the CDC called this calamity the worst drug-overdose epidemic in U.S. history (Kolodny et al., 
2015). 
Naliboff et al. (2011) conducted a 12-month prospective randomized clinical trial to 
compare the effectiveness of conservative opioid prescribing strategies with liberal dose-
escalation strategies on pain relief, functionality, and misuse outcomes. The researchers recruited 
a sample of 130 patients exclusively from the pain clinic of the Veterans Affairs Health Care 
System of Greater Los Angeles. Accounting for similar variabilities of sex and age among two 
groups (94% male with an average age of 52.6 years), the authors showed a significantly greater 
rate of increase in the liberal prescribing strategy of opioid-medication dosages compared with 
the conservative dose group. Patients in the liberal-dosing strategy experienced an 80% increase 
in opioid dosage over the 12 months, whereas the conservative group showed only a 16% 
increase in dosage. The liberal group showed a modest benefit in self-reported pain relief with 
the liberal-dosing strategy but not in disability functioning. Naliboff et al. concluded the liberal 
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escalating-dose group experienced more immediate decreases in pain after taking medication 
than those in the conservative group. However, the effect did not last or did not translate into any 
group differences in pain scores or greater functioning (Naliboff et al., 2011). One simple 
explanation for this phenomenon was the repeated doses needed and tolerance built over time to 
a single dosage and a single medication. Tolerance is common problem when prescribing 
narcotics but may easily be overlooked by inexperienced practitioner, who is unfamiliar with 
pain pathology and nociceptive receptor theory. It is in this regard that practice guidelines are 
most relevant. 
Practice Guidelines 
The American Institute of Medicine (1990) defined clinical-practice guidelines as 
“systematically developed statements to assist practitioner and patient decisions about 
appropriate health care for specific clinical circumstances” (p. 6). A decade later, the IOM added 
that clinical-practice guidelines are statements intended to optimize patient care. Furthermore, 
practice guidelines include statements and recommendations resulting from consensus-based 
systematic reviews of research evidence, an assessment of the benefits and harms, and alternative 
care options, addressing the manner in which patients with a specific condition should be 
managed. Moreover, guidelines may identify one or multiple strategies for treatment and are 
advisory rather than compulsory suggestions to influence practitioners’ adoption of evidence-
based practices in the clinical setting (IOM, 2011). Practice guidelines may be developed by 
variety of specialist disciplines from pediatric to geriatric governing bodies. Practice guidelines 
can also be developed by varied professional organizations both regionally and locally. Such that 
common medical issue may have clinical practice guideline can be developed separately by 
physician specialty and, Advance Nurse Practitioner specialty. Multiple clinical guidelines on 
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same or similar medical issue may be perplexing to a busy practitioner leading to more 
disengagement from adopting suggested guidelines.  
CDC Practice Guidelines 
The nation's premier health protection agency, CDC, holds public trust with a mission to 
save lives and protect people from health threats and epidemics. The agency fulfills its mission, 
through conducting research, data collection and disseminating health information that protects 
the public against expensive and dangerous health threats, both contagious and noncontagious. 
CDC guidelines are developed in response to potential or actual threat to the national public 
health. Operating under the U.S. Department of Health and Human Services, the CDC is a highly 
influential agency where stakeholders, payers, and policymakers, including medical boards and 
prescribers, are often swayed by its influence. In general, CDC Guideline are voluntary and 
nonbinding recommendations (CDC, 2016; Dowell et al., 2016). However, practical implications 
can affect prescribers treating patients (Baker, 2017). CDC’s recommendations may have far-
reaching consequences, if adopted into state standards, that require legal compliance. 
Additionally, insurer use of the guidelines may create hardships for beneficiaries to obtain 
prescribed medications (Zur & Tolbert, 2018).  
It has been clearly established that opioid related mortality has become a national threat 
to public of epidemic proportion. Medical practitioners prescribing practices and pharmaceutical 
availability has contributed, if not compounded this deadly epidemic. In March 2016, the CDC 
released the Guidelines for Prescribing Opioids for Chronic Pain. The CDC purposefully crafted 
the guidelines to improve the risks and benefits of opioid therapy for CNCP patients by 
enhancing the safety and effectiveness of management and decreasing the risks of opioid-use 
disorder and opioid-overdose-related deaths (CDC, 2016). The guidelines provide a total of 12 
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recommendations. Among the advisory statements are three guiding principles that frame the 
recommendations. First, opioid therapy should not be the initial suggested intervention for 
CNCP. Nonopioid interventions include physical therapy, cognitive-behavioral therapy, and 
nonopioid medications such as acetaminophen or nonsteroidal anti-inflammatory medications. 
The second principle aims to reduce the risk of opioid-use disorder and overdose. In this 
category, recommendations identify using the lowest effective dosage of opioid > 50 morphine 
milligram equivalent per day (MME/day) and titrating with caution to a maximum dosage of 90 
MME/day. The third principle addresses prudent prescriber oversight and patient follow up. In 
this category, the CDC (2016) encouraged prescribers to incorporate a plan for risk-mitigation 
strategies such as avoiding concurrent benzodiazepine prescriptions, prescription drug 
monitoring programs, urine drug testing, and methadone referrals. 
Practitioners can access many guidelines for opioid-safety prescribing, all with similar 
recommendations of using risk-assessment tools; physician–patient-informed signed contracts, 
monitoring strategies for aberrant behaviors by urine drug testing, pill counts, and prescription-
drug monitoring programs (Kahan et al., 2011; Manchikanti, 2012, 2011). Prior to the April 2016 
CDC Guidelines, no recommendations placed a ceiling for MME/day on dosages for prescriptive 
opioid analgesics (Duensing et al., 2016). The CDC Guideline created a great deal of discourse 
among pain advocacy groups and professional organizations regarding potential ramifications 
that may result from the severity of the restrictions on the prescribing liberties of practitioners 
(McMullen & Howie, 2011). 
The influence of the CDC’s has made a direct and swift impact on Veterans Affairs and 
the Department of Defense, which have implemented the CDC Guideline into their systemwide 
opioid-management strategies (Brennan et al., 2016; Department of Veterans Affairs, 2017; 
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Gellad, Good, & Shuklin, 2017). Additionally, individual state legislators have followed suit, 
with approximately 28 states passing dosing limits on opioid prescriptions (Blackman, 2018). 
Last and most noteworthy, the Centers for Medicare and Medicaid Services (2018) enacted 
regulations, effective in 2019, that place a hard audit trigger on beneficiaries who reach 
cumulative MME daily doses of 90 MME, as established by CDC Guidelines. Also adopted from 
the CDC Guidelines, Medicare Part D will require additional authorizations in the case-review 
process for prescriptions exceeding 90 MME (Centers for Medicare and Medicaid Services, 
2018). 
After an extensive review of literature on the 2016 CDC opioid-prescribing guidelines, 
little literature described prescribers’ familiarity and knowledge of the content, or their attitudes 
on the benefits of individual patients’ pain management and overall control of the opioid 
epidemic.,  Several themes that arose relating to guideline adherence. There seemed to be vast 
educational gaps in provider knowledge. Providers may have been familiar with guidelines but 
did not have detailed understanding of the content. Additionally, the providers had conflicting 
recall of guidelines specific to organization, state, and association. This can be contributed due to 
lack of alignment across authoritative bodies that release guidelines. These influence provider 
nonadherence to best-practice guidelines, and cause lack of provider confidence, as well as low 
provider satisfaction in managing patients with CNCP. This is a very relevant topic that warrants 
further exploration to better understand the knowledge, attitudes, and practices of primary care 
practitioners and their intention to accept or reject recommendations in their primary practice 
settings. In researching the gap stemming from the lack of literature and information on 2016 
CDC Guidelines, enlightening and meaningful results from this study contribute to practices that 
may shift opioid-prescribing practices. 
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Current Attitudes, Practices opioid prescribing and chronic pain management 
Practitioners throughout United States have varied attitudes and approaches to treatment 
of chronic pain management and opioid prescribing. Wolfert et al. (2009) studied Wisconsin 
physicians’ knowledge, beliefs and attitudes toward opioid analgesic use and discovered  that 
most physicians believed that it was acceptable medical practice to prescribe opioids for chronic 
cancer pain, but only half believed that prescribing opioid should be utilized for non-cancer 
patients. The study also revealed approximately, two-thirds of physicians were not concerned 
about being investigated for their opioid prescribing practices, but some feared of potential for 
investigation that led them to lower the dose prescribed, limit the number of refills for narcotics. 
Additionally, among those surveyed 40% of physicians incorrectly thought that both federal and state 
laws restricted physicians' prescriptions to only a 30-day supply of narcotics. Furthermore, the study 
demonstrated that many physicians who prescribe opioids had a poor knowledge of prescribing 
requirements contained in federal and state-controlled substances regulations. While they recognized 
presence of guidelines, there was multiple sources of guidelines that practitioners noted but no single 
uniformly influential to their individual practice. 
Challenges of Prescribers’ Knowledge and Beliefs 
Jamison et al. (2014) surveyed primary care practitioners’ beliefs and attitudes of opioid 
prescribing and chronic-pain management. The year-long longitudinal study revealed 
practitioners had adequate opioid knowledge, but their knowledge of opioids was unrelated to 
attitudes on prescribing opioids. The authors studied a sample of 56 practitioners: physicians, 
nurse practitioners, and physician assistants from eight centers. Less than half of the practitioners 
(46%) worried about addiction but believed they were sufficiently trained in prescribing opioids. 
Furthermore 89% expressed concern about opioid misuse and 84% felt that managing CNCP was 
19 
stressful. Jamison et al. found differences in confidence levels between senior practitioners and 
junior practitioners. Junior providers expressed greater stress levels and decreased confidence in 
managing patients with CNCP and had greater concerns regarding opioid dependence than more 
senior providers (p < .05). 
Ebbert et al. (2017) investigated associations of attitudes, beliefs, and practice styles 
among clinicians prescribing opioids. In a large academic medical center, the authors studied 
responses from 720 practicing primary care prescribers—65% physicians and 35% midlevel 
practitioners—to assess (a) clinicians’ confidence in managing patients with CNCP, (b) attitudes 
regarding opioids as an effective tool for the treatment of CNCP and their satisfaction with 
clinical care for CNCP, and (c) consistency in the clinical approach to opioid prescribing. Of the 
prescribers, 94% asserted the importance of a consistent approach to opioid prescribing. 
However, only 47% of prescribers were confident in their professional ability to care for patients 
with CNCP, and 82% expressed reluctance about prescribing opioids for CNCP. The researchers 
used the chi-square statistic to test relationships between categorical variables. 
Clinicians who were familiar with the CDC (2016) guideline reported higher degrees of 
confidence in managing CNCP (74% vs. 61%, 95% CI = 1.09–1.35, chi square = 12.4, p < .01; 
Ebbert et al., 2017). Additionally, clinicians reporting familiarity with the CDC guideline were 
less likely to believe opioids were effective for CNCP (14% vs. 21%, 95% CI = 0.47–0.95, chi 
square = 5.2, p = .02). However, guideline familiarity did not align with provider reluctance to 
prescribe opioids to patients with CNCP (81% vs. 83%, RR = 0.98, 95% CI = 0.91–1.05, chi 
square = 0.38, p = 0.54). In the same study, Ebbert et al. evaluated practice styles and prescriber 
concerns based on familiarity with CDC guidelines. Of   961 participants, 74% disclosed they 
follow CDC recommendations, whereas providers who were aware of CDC Guideline were 
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twice as likely to report always or frequently screening their patients for depression (49% vs. 
24%, RR = 2.05, 95% CI = 1.59–2.64, chi square = 39.1, p < 0.001). Additionally, in line with 
CDC recommendations, these providers were also 44% less likely to prescribe concomitant use 
of benzodiazepines with opioids (7% vs. 13%, RR = 0.56, 95% CI = 0.35-0.89, chi square = 6.1, 
p = 0.01). Lastly, among the 67% of clinicians who were aware of the 2016 CDC Guideline for 
CNCP, only 47% sought additional training to increase their knowledge of opioid treatment for 
CNCP. Prescribers were more likely to have enrolled in prescription drug-monitoring programs 
if they were familiar with a patient who required intervention for opioid abuse or overdose (68% 
vs. 51%; 95% CI = 1.14–1.52; chi square =11, p < 0.01; Ebbert et al., 2017). 
A Canadian study of 710 family physicians discovered that 40% of practitioners correctly 
answered only two of nine opioid-related knowledge questions (Allen et al., 2013). Similarly, 
Wolfert et al. (2010) studied 216 Wisconsin-based primary care practitioners and found 
multilevel misconceptions about the prescribing of opioids. Additional knowledge deficits 
identified among prescribers include inappropriate continuation of opioids and inadequate 
monitoring of opioids (Allen et al., 2013). 
A small study considered burnout in physicians who care for chronic-pain patients and 
revealed more than 60% physicians who treated chronic pain-patients reported emotional 
exhaustion (Nathan, 2009). In the same study, about 37.5% reported experiencing high levels of 
depersonalization and 19.3% reported a low sense of personal accomplishment. Increased 
physician strain can hinder efficient and effective patient care (Nathan, 2009). Strain occurs 
when job demands are high and decisional autonomy is low. Additionally, increased physician 
strain can block effective patient care. Although workers in many medical disciplines experience 
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strain, chronic strain resulting in burnout was highest in disciplines with low levels of personal 
control, poor support systems, and high job demands and expectations (Nathan, 2009). 
Likewise, in a study of 61 practitioners, primary care prescribers reported low confidence 
and dissatisfaction in treating chronic-pain patients (Vijayaraghavan et al., 2012). The authors 
found significant gaps in practitioners’ knowledge of effective care to chronic pain patients. 
Most providers reported lack of satisfaction in treating CNCP with opioid therapy (Macerollo et 
al., 2014). Providers preferred to manage these patients in collaboration with a pain specialist 
(Macerollo et al., 2014). 
Although guidelines seek to improve patient care by influencing clinical practice, 
researchers showed that adoption of information is generally ineffective (Bero et al., 1998). In 
systematic review of 109 studies, Bero et al. (1998) concluded that clinical-practice guidelines 
have a minimal effect on influencing behavioral change among practitioners. Not surprising, 
effective interventions include reminders, multifaceted interventions, and continued educational 
meetings. A recent study by McCalmont et al. (2018) investigated familiarity with CDC 
Guideline and continuing education with provider characteristics’ influence on compliance with 
opioid-prescribing practices. The researchers used a cross-sectional design with 417 prescribers 
in rural Oregon. McCalmont et al. concluded that higher hours of continuing education positively 
impacted provider confidence in pain management use of CDC guidelines. 
While, chronic-pain management and opioid prescribing are well researched in the 
literature gaps exist specific to use of prescribing guidelines and best practice. Limited research 
exists describing the acceptability and utility of the 2016 release of the CDC guideline. To date, 
limited studies evaluated the value and effectiveness of the CDC opioid guideline. Additionally, 
research is needed to explore the facilitators and barriers that influence the implementation of 
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opioid prescribing guidelines. Lastly, while many studies have examined knowledge, attitudes, 
and beliefs regarding chronic pain they have not focused on midlevel practitioners. Given the 
increase in midlevel practitioners in the primary care model, it would be prudent to include the 
perspectives of nurse practitioners and physician assistants on chronic pain and guideline 
implementation. 
Gap in the Literature 
To date, limited studies evaluated the value and effectiveness of the CDC opioid 
guideline. Additional research is needed to explore the facilitators and barriers that influence the 
implementation of opioid prescribing guidelines. Lastly, many studies of provider knowledge, 
attitude, and beliefs of the management of chronic pain are exclusive of midlevel practitioners. 
Given the increase in midlevel practitioners in the primary care model, it would be prudent to 
include the perspectives of nurse practitioners and physician assistants on chronic pain and 
guideline implementation. 
Theory and Conceptual Framework  
Despite the dissemination of guidelines by authoritative agencies, successful clinical-
guideline implementation, and adherence by medical practitioners to the suggested guidelines 
have had variable effect on practitioners’ behavioral changes (Rashidian et al., 2008). Clinical 
guidelines are not always easily accepted and implemented by practitioners. There is no singular 
theory that explains clinical guidelines adoption and adherence. The multifactorial components 
that influence practitioner’s choice of clinical guideline adoption can be explained through the 
lens of Diffusion of Innovation Theory by E.M Rodgers.  
 Diffusion of Innovations theory (DIT, Figure 1) offers a useful theorical support for 
guideline adoption. Although utilized in the discipline of business and marketing, DIT provides 
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an insight for understanding complexities inherent in the process of adopting novel ideas and 
practices (Rogers, 1995). This theory suggests that the adoption of an innovation, in this case 
guidelines, involves interaction between (1) the individuals adopting the innovation and (2) the 
innovation itself. Rogers (1995) explains the presence of four key  factors that influence the rate 
of adoption: (1) the adopter's perception of the relative advantage of the innovation; (2) the 
compatibility of the innovation with current practices; (3) the perceived degree of difficulty in 
the implementation (4) and  the visibility of outcomes resulting from adoption of the innovation. 
 
 
Figure 1. Diffusion of Innovation (DIT) Theory, E.M. Rogers 1962.  
 
A second contributing conceptual framework that supports this study is the Knowledge, 
Attitude and Practices model. The KAP model proposes that practice is influenced by the two 
constructs of attitude and knowledge. The model identifies the knowledge construct through 
awareness and familiarity and the attitude construct through agreement, motivation and outcome 
expectancy that lead to practice. Knowledge, attitude, and practice studies fundamentally assume 
a linear association between knowledge, attitude, and behavioral change (Figure 2).  
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Figure 2. The Knowledge-Attitude-Practice Model (Bano et al., 2013) 
Conceptual frameworks and theories are critical to understanding behavior patterns 
toward compliance with and adherence to guidelines. Fisher et al. (2016) analyzed a qualitative 
study built on Cabana’s original framework of knowledge, attitude, and behavior framework, 
dividing barriers to guideline implementation into subparts: knowledge (lack of awareness or 
familiarity), individual (lack of motivation), and external (guideline and patient related; Cabana 
et al., 1999). 
Scholars in many disciplines have addressed the issue of clinical-guideline compliance 
through various industry lenses. Disciplines that have contributed frameworks to adherence and 
compliance frameworks include sociology, psychology, engineering, organizational 
management, nursing medicine, and informatics (Gurses et al., 2009). After analysis of the 
contributions of various disciplines, Gurses et al. (2009) created a conceptual model to remedy 
guideline adherence with focused concentration on the following four major defining 
characteristics: clinician characteristics, system characteristics, guideline characteristics, and 
implementation characteristics. Cabana et al. (1999) are most recognized for identifying 
clinician-related characteristics, which include clinician knowledge due to lack of awareness of 
guidelines, clinician attitude related to lack of agreement with the guideline, and skepticism or 
lack of outcome expectancy. External barriers were the ambiguity of guidelines and practicality. 
Cabana et al. (1999) identified three barriers toward guideline compliance related to 
clinicians’ characteristics: clinician knowledge, clinician attitude, and external factors (Figure 3). 
Knowledge Attitude Practice
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First, the clinician-knowledge components may result from lack of familiarity with or lack of 
awareness of the guidelines. Second, clinician attitude may reflect lack of agreement with the 
specific guidelines or interpretation of the evidence and applicability to the patient. Lack of 
agreement also includes clinician perceptions that the recommended guideline is too restricting 
and impractical (Cabana et al., 1999). Additional attitudinal components are skepticism or lack 
of outcome expectancy that the suggested recommendation will lead to the desired outcome. 
Last, the attitudinal component includes lack of motivation or inertia of formerly cemented 
practice routines. The third element is the influence of external variables, where patient 
preference presents as a barrier, possibly accompanied by the presence of other environmental 
factors such as time constraints, lack of resources, and lack of reimbursements.  
 
Figure 3. Barriers to Physician Adherence to Practice Guidelines in Relation to Behavior Change 
(Cabana et al., 1999). 
.  
Although other models and theories exist, no singular model or framework explains with 
absolute clarity the degree of practitioner compliance toward established guidelines. One reason 
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may be the complexity of the health care industry and the degree of complexity of clinical 
guidelines involving multiple stakeholders and subspecialty disciplines. An example is the 2016 
CDC opioid guidelines for CNCP management, directed specifically to primary care 
practitioners. However, physicians are only one segment of professionals affected by these 
guidelines. Primary care providers also include advanced practice nurses and physician 
assistants. Additionally, affected by the 2016 CDC Guideline for CNCP management are 
pharmacists, and health care insurers. Therefore, a framework necessary to address the 2016 
CDC Guideline on chronic CNCP management ought to be more encompassing and use an 
interdisciplinary approach that includes multiple lenses to evaluate factors affecting authoritative 
guideline compliance. It is important to highlight that knowledge or attitude, is not necessarily a 
strong predictor of behavior alone (Ajzen & Fishbein, 1977). Individualized experiences such as 
years in clinical practice or exposure to regional population behaviors adds to practitioner biases 
that may influence practice behaviors. Lastly, the addition or lack of continuing education in a 
specific area of practice can heavily influence changes in practice behavior. A proposed hybrid 
model is presented to support as a foundation of this study (Figure 4). 
 
Figure 4. Conceptual Framework of the Study.  
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The pervasiveness of prescription opioids has clearly negatively impacted the health care 
industry. To combat the deleterious effects on society and the economy, the CDC (2016) has 
moved to disseminate guidelines and recommendations to rein in the opioid epidemic. 
Historically, guidelines have not been easily adopted into clinician practices, due to variety of 
barriers. To date, limited research studies investigated knowledge, attitude, and practices relating 
to the 2016 CDC guidelines. This gap in the literature renders this study relevant and timely. 
Using this framework, the study design will answer the following research questions. 
Research Questions 
1. What is the relationship between the amount of provider’s post licensure training relating to 
the area of chronic pain management (CPM) and 
a. The provider’s knowledge of the 2016 CDC Guideline. 
b. The provider’s belief that that the 2016 CDC Guideline will reduce the epidemic opioid 
crisis. 
c. The provider’s belief that the implementation of the 2016 CDC Guideline will produce 
improved outcomes in CPM. 
Research Hypothesis H1a. There is a statistically significant relationship between the amount 
of provider’s post licensure training in CPM and the provider’s knowledge of the current 
CDC Guideline. 
Research Hypothesis H1b: There is a statistically significant relationship between the amount 
of provider’s post licensure training relating to area f CPM and the provider’s belief that 
that the current CDC Guideline will reduce the epidemic opioid crisis in relation to CPM. 
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Research Hypothesis H1c: There is a statistically significant relationship between the amount 
of provider’s post licensure training in CPM and the provider’s belief that the 
implementation of the current CDC Guideline will produce improved outcomes in CPM. 
2. What is the relationship between the amount of provider’s years’ experience and 
a. The provider’s knowledge of the 2016 CDC Guideline. 
b. The provider’s belief that that the 2016 CDC Guideline will reduce the epidemic 
opioid crisis. 
c. The provider’s belief that the implementation of the 2016 CDC Guideline will 
produce improved outcomes in CPM. 
Research Hypothesis H2a: There is a statistically significant relationship between the amount 
of providers’ years’ experience and provider’s knowledge of the current CDC Guideline. 
Research Hypothesis H2b: There is a statistically significant relationship between the amount 
of provider’s years’ experience and the provider’s individual attitude that the current 
CDC Guideline will reduce the epidemic opioid crisis in relation to CPM. 
Research Hypothesis H2c: There is a statistically significant relationship between the amount 
of provider’s years’ experience and the provider’s belief that the implementation of the 
current CDC Guideline will produce improved outcomes about CPM. 
3. What is the relationship between the provider’s knowledge of the most current CDC Guideline 
and 
a. The provider’s belief that that the newest CDC Guideline will reduce the 
epidemic opioid crisis in relation to CPM. 
b. The provider’s belief that the implementation of the most current CDC Guideline 
will produce improved outcomes in CPM. 
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Research Hypothesis H3a: There is a statistically significant relationship between the provider’s 
knowledge of the newest CDC Guideline and the provider’s belief that that the CDC 
Guideline will reduce the epidemic opioid crisis in relation to CPM. 
Research Hypothesis H3b: There is a statistically significant relationship between the provider’s 
knowledge of the CDC Guideline and the provider’s belief that the implementation of the 
current CDC Guideline will produce improved outcomes in CPM. 
4. What is the relationship between the provider’s belief that the CDC Guideline will reduce the 
epidemic opioid crisis in relation to CPM and the provider’s belief that the implementation of 
the CDC Guideline will produce improved outcomes with regard to CPM? 
Research Hypothesis H4: There is a statistically significant relationship between the 
provider’s belief that the CDC Guideline will reduce the epidemic opioid crisis in 
relation to CPM and the provider’s belief that the implementation of the CDC 
Guideline will produce improved outcomes with regard to CPM. 
5. Do either of following variables act as mediators between the provider’s knowledge of the 
2016 CDC Guideline and the provider’s attitude regarding the implementation of the 2016 
CDC Guideline recommendations in his or her own practice? 
a. The provider’s belief that the 2016 CDC Guideline will reduce the epidemic 
opioid crisis in relation to CPM 
b. The provider’s belief that the implementation of the 2016 CDC Guideline will 
produce improved patient outcomes in CPM. 
Research Hypothesis H5a: The provider’s belief that the 2016 CDC Guideline will reduce 
the epidemic opioid crisis in relation to CPM acts as a mediator between the 
provider’s knowledge of the 2016 CDC Guideline and the provider’s attitude 
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regarding the implementation of the 2016 CDC Guideline recommendations in his or 
her own practice. 
Research Hypothesis H3a: The provider’s belief that the implementation of the 2016 CDC 
Guideline will produce improved patient outcomes with regard to CPM acts as a 
mediator between the provider’s knowledge of the 2016 CDC Guideline and the 
provider’s attitude regarding the implementation of the 2016 CDC Guideline 
recommendations in his or her own practice 
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CHAPTER III 
METHODOLOGY 
A thorough consideration was given to utilizing an appropriate methodology to meet the 
aims of the study. Among the methods considered were qualitative methods, quantitative 
methods, and a mixed methodology. Quantitative methods best matched the aims of the study. 
The reasons for the quantitative methods are primarily directed from McCalmont’s research 
study utilizing the study tool, as this study replicates with established measurement of Likert 
scales. The quantitative methodology is less biased and objective measure to quantify behaviors, 
opinions, attitudes, and generalize from a larger population. Furthermore, the quantitative data is 
precise, reliable, and consistent, and repeatable. Among the factors to be considered in the 
quantitative study were an appropriate research design, developing a survey instrument that 
would allow for collection of sufficient data to calculate the study variables needed to answer the 
research questions, deciding which statistical tests would be most appropriate, and determining a 
target sample size that would produce sufficient power for the statistical analyses. The PI 
considered the best option to obtain a representative sample of participants to test the research 
hypotheses for the desired targeted population, given the time and resource constraints applicable 
to practicing providers who constituted the sample. Once these decisions were made, the PI 
directed the focus toward how to best conduct the study to ensure participants met eligibility 
requirements the surveys were administered with integrity and confidentially, and the data 
accrued from the surveys were complete and free of errors. 
Research-Study Design 
The design for this quantitative non-experimental cross-sectional design. The intentional 
choice to use a cross-sectional design rests with the advantage that it captures participant data at 
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a single point in time rather than at several consecutive times, as in longitudinal studies (Field, 
2018). Another advantage to a cross-sectional study design is that it eliminates the chance that 
history or testing effects will distort influence on participants’ scores, as could happen with a 
longitudinal design (Portney & Watkins, 2009). The advantage to longitudinal studies is the 
ability to show patterns of a variable over time. However, longitudinal designs are time intensive 
as well as costly. Additionally, there is greater risk for participant attrition and require larger 
population samples. This study was cross-sectional because each medical provider participating 
in the study completed the survey instrument in a single sitting and only once. The entire data-
collection phase of this study took place in a relatively short period of time (3 months), further 
minimizing the potential influence that the passage of time might have had on study results. The 
benefit of a cross-sectional study over longitudinal study design is that it allows researchers to 
compare many different variables at the same time. 
The nature of this study was correlational. Correlational studies explore the relationships 
among two of more variables captured by the study (Portney & Watkins, 2009). This study 
clearly fits this definition, as the first three research questions aimed to measure the degree of 
associations among the following variables: providers’ amount of post licensure training during 
the past 3 years in CNCP management; the provider’s knowledge of the contents of the 2016 
CDC guidelines; the providers’ belief that the 2016 CDC Guideline would reduce the epidemic 
opioid crisis in relation to chronic-pain management; and their belief that the implementation of 
the current CDC Guideline would improve patient outcomes in chronic-pain management. A 
fifth research question addresses variable relationships, asking whether either of the two belief 
variables mentioned in the previous sentence acted as a mediator on the relationship between a 
33 
provider’s knowledge of the 2016 CDC guideline and their attitude toward implementing the 
recommendations in this guideline to their own practice. 
Sampling Procedure and Survey Implementation 
The target population for this study was physicians, physician assistants, and nurse 
practitioners located throughout the United States who treat and manage patients experiencing 
CNCP, who are aware of the 2016 CDC guidelines, and who hold prescriptive privileges 
including Schedule III medications, such as opioids. Exclusion criterion included physicians who 
had specialty training, physicians and practitioners in training and practitioners who responded 
as not having awareness of the 2016 opioid prescribing CDC guidelines. The rationale for the 
exclusion criteria for specialty trained physicians related directly to the guidelines intention of 
addressing generalist practitioners and not specialty practitioners. The second group that was 
excluded from the study of learner practitioners was due to lack of ability for decision making 
and prescriptive authority of narcotics. Lastly, providers who were unaware of the guidelines 
were excluded due to applicability of knowledge component of the guidelines would lead to 
skewed results.    
The survey instrument was electronically disseminated through three national 
professional associations: the American Association of Nurse Practitioners, the American 
Association of Physician Assistants, and the Academy of Family Practice Physicians. These 
organizations made the survey tool available to their members for a specified window of time (3 
months), either on their respective websites or by email invitation containing a link to the survey. 
The rationale behind this approach was to make the survey tool accessible to physicians, 
physician assistants, and nurse practitioners located throughout the United States. The 
professional associations tend to have a wide range of members with varying experience and 
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training in their respective fields. The goal was for the study to yield a nationally representative 
sample of Family practice physicians, physician assistants, and nurse practitioners who had 
various levels of post licensure training (ranging from none to many hours) in the area CNCP 
management. Prior to initiating and deploying the survey tool, the PI submitted and obtained 
approval for this study from the Seton Hall University Institutional Review Board (SHU-IRB; 
(see Appendix A). 
Determination of Target Sample Size 
Prior to commencing the data-collection phase of the study, the PI had to obtain an idea 
of the range of sample sizes needed for the analyses to produce sufficient levels of statistical 
power. The standard of sufficient statistical power employed for this purpose was 1 -  = .80. To 
obtain these recommended sample sizes, a G*Power tool was run on an a priori basis, assuming 
an α level of 0.05 with small, medium, or large effect sizes (See Appendix B). As the  PI used 
correlational tests Pearson’s r, to evaluate the first six research hypotheses, the statistic used to 
measure effect size for each test was the absolute value of the respective correlation coefficient 
(i.e., |r| for Pearson, with values of 0.10, 0.30, and 0.50 used to represent small, medium, and 
large effect sizes, respectively (Cohen, 1988). 
The PI also ran a priori G*Power analyses for the final research hypotheses, which 
involved mediational path analyses. Because the required sample sizes for the correlational 
components of these path analyses were already obtained from the G*Power performed for the 
first six research hypotheses, what remained was running the G*Power for the multiple 
regression components of the path analyses. These latter G*Power analyses assumed an α level 
of .05 and two predictor variables (i.e., the knowledge variable and the appropriate belief 
variable) along with small, medium, or large effect sizes. Based on the standards promulgated by 
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Cohen (1988) for regression models, the small, medium, and large effect sizes corresponded with 
the coefficient of determination (R2) values of 0.01, 0.06, and 0.14, respectively. The 
recommended sample sizes produced by these various a priori G*Power analyses (Table 1). 
 
Table 1.  
Recommended Sample Sizes 
Research hypotheses Small effect size (n) Medium effect size (n) Large effect size (n) 
1a, 1b, 1c, 2a, 2b, 3 616 67 23 
4a and 4b 957 143 63 
 
The PI focused on the recommended sample sizes for Research Hypotheses 4a and 4b, as 
they were greater than the corresponding recommended sample sizes for the other six 
hypotheses. A minimum sample size of n = 957 would be required for sufficient power of 1 -  = 
0.80 if either of the multiple regressions run for Research Hypotheses 4a or 4b produced a small 
effect size that was statistically significant. In practice, however, it is more common for 
statistically significant results to have effect sizes in the medium to large range. Therefore, 
initially the researcher planned to obtain at least n = 143 eligible participants to complete the 
survey instrument for the study.  
The survey tool contained eligibility questions designed to eliminate potential 
participants who were not part of the targeted population of the study, as well as safeguards 
designed to ensure that all items in the survey were answered properly before the survey could be 
submitted, the PI was not concerned that any of the survey data was  received would have to be 
discarded due to ineligible participants, input errors, or incompleteness. The researcher planned 
to run G*Power on a post hoc basis after performing each statistical test to determine the attained 
36 
statistical power level for that test. If any of these power levels fell short of the 1 -  = 0.80 
standard, the researcher had planned to recruit additional participants and rerun the statistical 
analyses with these additional surveys such that the increased sample size would produce 
sufficient power. 
Survey Instrumentation 
The PI used an existing survey tool published in Journal of Opioid Management in 
original research by McCalmont et al., (2018). Lead author permission was obtained through 
electronic communication. The questionnaire did not fall under copywrite restriction; thus, 
request for copyright permission was obviated. The study included III sections. Section I was 
dedicated to demographics inquiries of age, profession, years in practice, ethnicity/race, practice 
type and practice region. Section II inquiry related to awareness of 2016 CDC guidelines. 
Section III Likert scaled statements relating to beliefs and attitudes of 2016 CDC opioid 
prescribing guidelines. The PI built upon this study by incorporating a section on factual recall of 
2016 CDC opioid guideline recommendation, form of multiple-choice questions. This section 
was discussed at length with guidelines authorship team for accurate representation of CDC 
guidelines. The study was disseminated in an electronic format (see Appendix C), utilizing 
Survey Monkey platform. The decision to develop a computer-based survey tool was to allow for 
a wide dissemination of the survey to the targeted audience through the internet; to eliminate the 
need to secure physical locations, printed materials, and personnel to administer the survey to 
participants; and to reduce the incidence of ineligible or incomplete surveys, as the survey 
instrument itself contained safeguards to flag or prevent these problems. A computerized survey 
format also permitted the PI to download the survey data collected from the group of participants 
directly into an electronic medium (a Microsoft Excel® spreadsheet) for further compilation. 
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The PI designed the electronic survey-dissemination process to protect the confidentiality 
of participants, as email addresses were not accessible to the researcher. Further,  the anonymity 
of participants were ensured  due to the absence of any personal identifiers on the survey 
instrument, such as name, physical address, telephone number, names of any employers or 
schools attended, social security number, or Drug Enforcement Administration registration 
number. The initial disclosure statement in the solicitation letter sent with the survey tool clearly 
stated the voluntary nature of the survey and its low risk to the participants. The survey 
instrument consisted of the following five sections. 
Demographics 
Demographics of the survey included questions designed to obtain descriptive 
information about the medical-provider participant such as age, level of education, profession 
(physician, physician assistant, nurse practitioner), years of experience as a medical provider, the 
state where the provider currently practices, and the provider’s number of post licensure 
continuing medical education hours (CME) over the past 3 years in CNCP management. In 
addition, this section contained two eligibility questions: whether the participant was aware of 
the 2016 CDC guideline and whether the participant had a Drug Enforcement Administration 
registration number. Negative responses to either of these questions disqualified the participant 
from the study because the focus of the study was only on those providers who had awareness of 
the existence of the CDC guideline for prescribing opiates and those who were legally permitted 
to prescribe opiates. 
The items in this section used to answer the research questions were the providers’ CME 
hours over the past 3 years in CNCP management and providers’ years of experience. Relating to 
the CME inquiry, participants selected from a drop-down menu denoting one of six ranges for 
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this variable: 0 (i.e., no training); 1–4 hours; 5–9 hours; 10–19 hours; 20–29 hours; and 30 hours 
or more. The rationale for using ranges to report this variable was related, in part, to the 
realization that the provider participant may not have been able to recall their exact number of 
hours of CNCP management training during the past 3 years but could select the appropriate 
range in which these earned hours of CME for pain management fell. The researcher also 
thought it important to include a “0 (no training)” category to distinguish those participants who 
had no recent CME in pain management. In developing this set of ranges, A concerted effort was 
made to include enough ranges to differentiate participants with only a little post licensure 
training in pain management from those who had moderate and significant amounts of CME 
training in this area. An additional relevant factor was that states’ requirements regarding the 
amounts of continuing education medical providers must receive in their areas of practice varied 
from very lax to significant. 
Knowledge of the 2016 CDC Guideline 
This section consisted of specific objective questions regarding the contents of the most 
current CDC opioid prescribing guideline. Each of the 12 questions in this section was multiple 
choice in nature with four potential answer choices (labeled A, B, C, and D) for each question. 
Participants’ composite scores in this section were the number of these questions answered 
correctly. The questions drew directly from the CDC website on the self-evaluation tool for 
opioid prescribing guidelines, with permission. https://www.medscape.org/viewarticle/881589. 
https://emergency.cdc.gov/coca/calls/2018/callinfo_031318.asp.; Additionally, the researcher 
contacted the guideline authors who provided input on the final version used in this study. 
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Study Variables 
To answer the research questions, the researcher compiled the following items from the 
survey instrument for each study participant: The variables evaluated in this study were four 
predictor variables and two outcome variables. Since, this study was not experimental design 
study, the need for control variables were obviated. 
Predictor or Independent Variables: 
1. The number of hours of post licensure training over the past 3 years in CNCP 
management. 
2. The number of years in practice. 
3. The composite score on knowledge of the 2016 CDC guideline (Knowledge). 
4. The composite score on the belief that the 2016 CDC guideline would reduce the 
epidemic opioid crisis in relation to chronic-pain management (Belief). 
Outcome or Dependent Variables: 
1. The composite score on the attitude that the 2016 CDC guideline would produce 
improved outcomes in chronic-pain management (Individual Attitude). 
2. The composite score on the participant’s attitude regarding the implementation of 
the 2016 CDC guideline recommendations concerning reducing the chronic 
epidemic opioid crisis in their own practice (Practice 1 and 2). 
The number of hours of post licensure training, is an ordinal variable because the six 
possible choices for the range in which the participant’s hours of post licensure CNCP training 
over the past 3 years has a natural order. In contrast, the composite score on the knowledge of the 
CDC guideline is a ratio-level variable because this score is a true number (hence, differences 
between any two scores are meaningful) with a natural zero point (Field 2018). 
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Each of the latter four items on the list shown above are sums of Likert-style scores that 
are ordinal-level variables. Although some statisticians believe that a sum of Likert scores 
produces a composite variable that is ordinal (but not interval) in nature and hence to which 
researchers can only apply nonparametric statistical tests, other researchers have gained 
consensus and are comfortable applying parametric methods to these types of composite 
variables under certain conditions (Sullivan & Artino, 2013). These criteria include the 
following: using a minimum 5-point Likert-type scale for each individual survey item 
contributing to the composite variable, including at least five individual Likert-type scores to 
obtain the composite variable, and testing to see whether the composite variable is normally 
distributed (Grace-Martin, 2012). Sullivan and Artino also suggested a minimum sample size of 
at least five participants when performing statistical tests with this type of composite variable. 
Table 1 summarizes the assigned name, description, measurement level, method of calculation, 
and possible score range of each of these six variables. 
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Table 2  
Summary of Attributes of Variables Used in Analysis 
 Description 
Measurement 
level Method of calculation 
Possible score 
range 
(CME)_HRS Number of hours of post licensure 
training during past 3 years in CNCP 
management 
Ordinal Select appropriate 
range from 6 possible 
choices 
Choices range 
from “0 (i.e., 
no training)” 
to “30 hours or 
more” 
KNOWLEDGE Composite score on knowledge of 
2016 CDC guideline 
Ratio Number of correctly 
answered questions on 
a 12-item objective 
multiple-choice test 
0–12 
OPIOID_BELIEF Composite score on belief that 2016 
CDC guideline will reduce chronic 
opioid crisis in relation to CNCP 
management 
Ordinal Sum of scores on 6 9-
point Likert-type scale 
items 
6–30 
ATTITUDE Composite score on attitude that 2016 
CDC guideline will produce improved 
patient outcomes in CNCP 
management 
Ordinal Sum of scores on 10 
9-point Likert-type 
scale items 
10–50 
PRACTICE I 
(REDUCE HARM) 
Composite score on the participant’s 
attitude regarding implementation of 
the 2016 CDC guideline 
recommendations concerning 
reducing the chronic opioid crisis in 
their own practice 
Ordinal Sum of scores on 6 9-
point Likert-type scale 
items 
6–30 
PRACTICE 2 
(Increase 
Modalities) 
Composite score on the participant’s 
attitude regarding implementation of 
the 2016 CDC guideline 
recommendations concerning 
improved patient outcomes in their 
own practice 
Ordinal Sum of scores on 10 
9-point Likert-type 
scale items 
10–50 
Note. CME = continuing medical education, CNCP = chronic non-cancer pain, CDC = Centers 
for Disease Control and Prevention. 
Belief That the 2016 CDC Guideline Would Reduce the Opioid Epidemic Crisis  
This section consisted of six statements about the provider’s perception regarding the 
effectiveness of the CDC Guideline in reducing the epidemic opioid crisis in relation to chronic-
pain management. Responses to each of these statements was on a 9point Likert-type scale (with 
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responses ranging from 1 = Strongly Agree to 9 = Strongly disagree). All statements in this 
section were positively worded; hence no reverse scoring was necessary. 
The researcher adapted the statements from a survey instrument (specifically, Item 5 of 
that survey) used in the study by McCalmont et al. (2018), with written permission, which 
investigated the impact of the 2016 CDC Guideline on Oregon medical providers. The researcher 
obtained a composite score by summing individual Likert scores for the 10 items appearing in 
the section. The PI eliminated one statement appearing in the original McCalmont et al. survey 
because the statement was specific to the Oregon Health Plan, thus not relevant to the current 
study. The alpha, as found in the results chapter, demonstrate that this removal did not impact the 
reliability of the scale.  
Attitude Regarding the Implementation of the 2016 CDC Guideline Recommendations in 
the Provider’s Own Practice 
This section contained 16 statements about a provider’s attitude regarding the 
implementation of the recommendations promulgated by the 2016 CDC guideline in their own 
practice. The responses to each of these statements was on a 9-point Likert-style scale (with 
responses ranging from 1 = Strongly Agree to 9 = Strongly disagree). The researcher grouped 
these statements into two parts: A and B. Part A consisted of six statements, each addressing the 
CDC recommendations regarding reducing the chronic opioid crisis, whereas the ten statements 
in Part B focused on CDC recommendations for improving CNCP patient outcomes. The PI 
obtained statements appearing in Part A by rewording statements from the third section of the 
survey (which addressed the belief that the CDC guideline would reduce the chronic opioid 
crisis), so they apply to the particular practitioner and their patients rather than to the medical 
profession as a whole. In a similar fashion, for Part B, the PI  followed the same steps regarding 
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the statements comprising the fourth section of the survey (focused on the CDC guideline’s 
impact on producing better patient outcomes), so they, too, would specifically address the 
attitudes of the medical provider in relation to their own practice. 
Prior to developing this section of the survey instrument, the PI reviewed the method 
employed by Kernodle (1998) to derive an attitudinal variable from their survey data for use in 
their study, which also addressed the adaptation of sets of practice guidelines by medical 
providers. Kernodle’s method built on Fishbein’s and Ajzen’s (1975) definition of attitude, 
which states that a combination of an individual’s behavioral beliefs and their appraisal of the 
relevant outcomes associated with those beliefs, determines a person’s attitude. To calculate the 
value of their attitudinal variable, Kernodle took the product between the Likert-type score for 
each item in the behavioral-beliefs section of the survey and the Likert-type score for the 
corresponding item (i.e., the outcome evaluation for that behavioral belief) in the attitudinal 
section of the survey and summed the products. 
Because Research Question 5 of this study investigates whether each of the two belief 
variables (derived in Sections III and IV of the survey instrument) acts as a mediator between the 
knowledge variable and the appropriate attitudinal variable (from either Part A or Part B of 
Section V of the survey), it is important that the belief variable and the corresponding attitudinal 
variable share no common elements in their derivations. Sharing common elements would result 
in a built-in correlation between these two variables, which would distort the outcome of the 
mediation path analysis. For this reason, the researcher did not apply the method described in the 
Kernodle (1998) study to derive composite scores for the attitudinal variables used in this study. 
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Validity and Reliability of the Survey Instrument 
The researcher addressed the validity and reliability of the various sections (other than 
the demographics section) of the survey instrument prior to collecting the data. In constructing 
the multiple-choice questions on knowledge of the 2016 CDC guideline section, the PI created 
questions that covered the content of all 12 recommendations detailed in the 2016 CDC 
document itself. Additionally, then researcher  believed this knowledge section would be highly 
reliable because the Cronbach’s alpha for this section of the survey tool in the McCalmont et al. 
(2018) study, which also addressed participants’ familiarity with the 2016 CDC Guideline (i.e., 
Item 8 of that survey), was α = .90. Further, the authors of the original 2016 CDC opioid 
prescribing content guidelines evaluated the knowledge section for face validity. The authors of 
the guideline writing team reviewed the knowledge content at three separate time periods. The 
researcher eliminated three questions due to concerns of ambiguity of answer choices, after 
consultation with guideline authors. Reliability was tested using Cronbach alpha, as seen in 
Chapter 4.  
Because the authors of the McCalmont et al. (2018) study did not discuss the issue of 
validity in relation to the sections of their survey (i.e., Items 5 and 17), which I adapted for use in 
the two belief sections of this study’s survey instrument, the PI relied on the method used by 
Kernodle (1998), in which the author solicited a group of experts in the field of behavioral 
characteristics related to guideline use and asked them to evaluate the validity of these sections 
of the survey. For reliability, the Kernodle study reported that the Cronbach’s alphas for the 
attitudinal sections of the survey tools designed to measure guideline compliance for four 
different medical practices ranged from α = 0.88 to α = 0.96. Despite some differences between 
the ways Kernodle calculated the composite value of the attitudinal variable and this study, the 
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researcher was confident that this section of my survey would also exhibit a high degree of 
internal consistency. Additionally, after deploying the survey instrument, the researcher 
conducted factor analysis on each of the sections discussed for validity appropriateness of 
constructs. 
Once the study data accrued, the researcher evaluated the reliability of the knowledge 
section of the survey, along with the reliabilities of the two belief sections and Parts A and B of 
the attitudinal section by calculating separate Cronbach’s alphas for each of these sections and 
parts. The PI recognized, however, that Cronbach’s alpha is not an appropriate tool to evaluate 
count variables (Cronbach, 1980). Considering this limitation, the researcher performed a 
principal-axis factor analysis on each section to determine the main constructs (i.e., factors) 
underlying the items in that survey section. This generated a matrix displayed for each survey 
item corresponding to the factor loadings of the main constructs. An examination of the 
magnitudes of these factor loadings allowed me to determine which of these constructs had the 
greatest influence on each item. Using this, scales were created. As a final step, the PI calculated 
separate Cronbach’s alphas for the scales shown in the factor analysis. Because the overall alpha 
value for a given survey section is an inappropriate measure of internal consistency when that 
scale has several underlying constructs (Field, 2018), this latter set of alphas by subscale 
provided a more accurate assessment of that section’s reliability (Cronbach, 1951). 
Data Compilation 
At the conclusion of the data-collection period, the researcher compiled and downloaded 
the information from the completed surveys into a Microsoft Excel spreadsheet. A single master 
spreadsheet was organized, each row contained the survey data for a particular participant, and 
each column contained responses across all participants on a data item in the survey. The top row 
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of the spreadsheet contained the SurveyMonkey-generated names for each survey item. To 
prepare this data file so it could be used for statistical analyses, the researcher carried out the 
following manipulations: 
 After reviewing the SurveyMonkey-generated names for each data item, the PI 
created and entered more descriptive names that adhered to SPSS-variable naming 
rules for these items. 
 For the number of CMEs, the PI created a new variable using Excel formulas, 
assigning a number to each of the six possible categorical selections for this item. 
These assignments were as follows: 1 for “0 (no such training)”; 2 for “1–4 hours”; 3 
for “5–9 hours”; 4 for “10–19 hours”; 5 for “20–29 hours”; and 6 for “30 hours or 
more.” 
 The researcher calculated the composite score on the knowledge of the 2016 CDC 
guideline, and the composite Likert-style scores for the reduction in the epidemic-
opioid-crisis belief variable, the improved-patient-outcomes belief variable, and the 
two practice attitudinal variables. 
 Last, for some of the nominal-level demographic variables (such as level of 
education, profession, state of practice, and type of practice), the researcher assigned 
a variable with a numerical code to each possible category of that variable. The PI 
created a new variable for the profession item, where an assignment of number 1 for a 
physician, 2 for a physician assistant, and a 3 for a nurse practitioner. 
Safeguards were created in the survey instrument to prevent the completion of the survey 
by an ineligible potential participant and to ensure participants completed all items before 
submitting the survey. Hence, there was no reason to clean the data by eliminating ineligible or 
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incomplete surveys. Once these steps were complete, the data was uploaded to IBM SPSS to 
perform the statistical analyses. 
Descriptive and Inferential Statistical Analyses 
After collecting, compiling, and uploading survey data to SPSS, the PI ran various 
descriptive and inferential statistical analyses on the data. 
Descriptive Analyses 
The descriptive analyses involved producing several tabular and graphical exhibits to 
obtain a better understanding of the characteristics of the medical providers included in the 
sample. Several exhibits provided information on the demographics of the sample such as age, 
level of education, profession (physician, physician assistant, or nurse practitioner), years of 
experience, geographic state of practice, type of practice, and the number of hours of CME 
training during the past 3 years in CNCP management. Additionally, the researcher produced 
tables and graphs summarizing participants’ responses for the remaining sections of the survey 
tool. These tables and graphs included exhibits summarizing key sample metrics (such as the 
mean, median, and standard deviation) for the composite scores calculated for each of these 
variables. 
Inferential Analyses 
Appropriate Inferential statistical tests were performed to test research hypotheses 
corresponding to each of the subparts of the five research questions. A summary of the 
inferential statistical tests chosen to evaluate each of the research hypotheses is detailed below. 
Each summary lists the study variables applicable to the given research hypothesis, the name(s) 
of the statistical test(s) conducted to evaluate that hypothesis, and a brief discussion of why the 
selected tests were appropriate. 
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Research Hypothesis 1a 
Variable 1. Number of hours of CME training during the past 3 years in CNCP 
management (CME_HRS)—Ordinal level 
Variable 2. Composite score on the knowledge of the 2016 CDC guideline 
(Knowledge)—Ratio level 
Research Hypothesis 1a states that a statistically significant relationship exists between 
the two variables listed above. The statistical test applied was Pearson’s correlation r. 
Researchers use Pearson’s correlation to find a linear relationship between two variables (Field, 
2018). 
Research Hypothesis 1b 
Variable 1. Number of hours of CME training during the past 3 years in CNCP 
management (CME_HRS)—Ordinal level 
Variable 2. Composite score on the providers’ belief that the 2016 CDC guideline would 
reduce the epidemic opioid crisis in relation to CNCP management (BELIEF)—Ordinal level 
Research Hypothesis 1b states that a statistically significant relationship exists between 
the two variables listed above. The statistical test applied was Pearson’s correlation r. 
Researchers use Pearson’s correlation to find a linear relationship between two variables. 
Research Hypothesis 1c 
Variable 1. Number of hours of CME during the past 3 years in CNCP management 
(CME_HRS)—Ordinal level 
Variable 2. Composite score on the providers’ belief that the implementation of the 2016 
CDC guideline would produce improved patient outcomes with regard to CNCP management 
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(BELIEF)—Ordinal level. The statistical test applied was Pearson’s correlation r. Researchers 
use Pearson’s correlation to find a linear relationship between two variables. 
Research Hypothesis 1c states that a statistically significant relationship exists between 
the two variables listed above. The statistical test applied was Pearson’s correlation r. Pearson’s 
correlation is used to find a linear relationship between two variables. 
Research Hypothesis 2a 
Variable 1. Composite score on the knowledge of the 2016 CDC guideline 
(KNOWLEDGE)—Ratio level 
Variable 2. Composite score on the belief that the 2016 CDC guideline would reduce the 
epidemic opioid crisis in relation to CNCP management (BELIEF)—Ordinal level 
Research Hypothesis 2a states that a statistically significant relationship exists between 
the two variables listed above. Because the _BELIEF variable is a sum of Likert-type scale 
variables, Sullivan and Artino (2013) and Grace-Martin (2012) suggested that if certain 
conditions are satisfied, this composite-score variable can be treated as an interval-level variable 
when running statistical tests, allowing the use of a parametric test. These conditions follow: a 
minimum of a 5-point Likert-type scale for each item included in the composite score, at least 
five individual Likert-type scale items comprising the composite score, a sample size of at least n 
= 5, and a distribution of the composite score variable that is approximately normal. The PI 
selected the Pearson’s r correlation as the parametric test for this research hypothesis because it 
is appropriate for measuring an association when both variables are either interval level or ratio 
level. The researcher ran the Pearson’s r correlation test on a two tailed basis to be consistent 
with the wording of the research hypothesis. 
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Research Hypothesis 2b 
Variable 1. Composite score on the knowledge of the 2016 CDC Guideline 
(KNOWLEDGE)—Ratio level 
Variable 2. Composite score on the belief that the 2016 CDC Guideline would produce 
improved patient outcomes with regard to CNCP management (OUTCOME_BELIEF)—Ordinal 
level 
Research Hypothesis 2b states that a positive relationship exists between the two 
variables listed above. The researcher selected Pearson’s r correlation as the parametric test for 
this research hypothesis because it is appropriate for measuring an association when both 
variables are either interval level or ratio level. The researcher ran the Pearson’s r correlation test 
on a right-tailed basis to be consistent with the wording of the research hypothesis. 
 
Research Hypothesis 3 
Variable 1. Composite score on the belief that the 2016 CDC guideline would reduce the 
epidemic opioid crisis in relation to CNCP management (Opioid Belief)—Ordinal level 
Variable 2. Composite score on the belief that the 2016 CDC Guideline would produce 
improved patient outcomes regarding CNCP management (BELIEF)—Ordinal level 
The PI selected the Pearson’s r correlation as the parametric test for this research 
hypothesis because it is appropriate for measuring an association when both variables are either 
interval level or ratio level. I ran the Pearson’s r correlation test on a right-tailed basis to be 
consistent with the wording of the research hypothesis. 
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Research Hypothesis 4a 
Independent variable. Composite score on the knowledge of the 2016 CDC guideline 
(Knowledge, CME training, Belief Scale, Individual Attitude Scale). 
Dependent variable. Composite score on the participant’s attitude toward implementing 
the CDC guideline recommendations concerning reducing the chronic opioid crisis in their own 
practice (Practice Scale I –Harm Reduction); (Practice Scale II-Non-Opioid Modalities) 
Intervening variable. Composite score on the belief that the 2016 CDC guideline would 
reduce the epidemic opioid crisis in relation to CNCP management (Opioid Belief)—Ordinal 
level 
Statistical tests. Mediation path analysis—Parametric 
To determine whether the intervening variable was acting as a mediator between the 
independent and dependent variables, the PI proposed a path analysis. Figure 5 presents a 
schematic diagram of this path analysis. The significance of utilizing this method is to help 
explain more clearly hypothesized patterns of directional and nondirectional relationships among 
a set of observed (measured) and unobserved (latent) variables (MacCallum & Austin, 2000). 
The purpose of the model, in the most common form of SEM, is to account for variation and 
covariation of the measured variables (MVs). With that in mind, a path diagram or a pictorial 
presentation was constructed as shown below to test relationships between dependent variables 
and multiple independent variables. Path analysis is useful because, unlike other techniques, it 
provides a focused view of relationships among all the independent variables. This results in a 
model showing directional mechanisms through which independent variables produce both direct 
and indirect effects on a dependent variable. A measured variable (MV) is a variable that is 
directly measured whereas a latent variable (LV) is a construct that is not directly measured. 
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Direct effect is a directional relation between two variables, e.g., independent, and dependent 
variables Indirect effect is the effect of an independent variable on a dependent variable through 
one or more intervening or mediating variables. While there are various programs that can be 
used in this analysis, the researcher chose to utilize SPSS supported AMOS software for the 
analysis. 
Figure 5 presents a schematic diagram of this path analysis. 
 
 
Figure 5. Path Analysis for Research Hypothesis 4a 
In Figure 5 represents the various paths that are included in the structural equation model. 
The a represents the path between the knowledge and individual attitude scale variables, whereas 
b represents the relationship between the opioid belief and both practice variables. Path c is the 
relationships between the knowledge and practice variables. Assuming a, b, and c are all 
statistically significant, the opioid belief variable can be considered a mediator between the 
knowledge and the two practice variables. To determine whether opioid belief is a mediator 
between the knowledge and the two practice variables, one must show that the inclusion of the 
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opioid belief variable as a predictor in the multiple regression model causes the significant 
relationship between the knowledge and opioid attitude variables to become either nonsignificant 
or to have a large reduction in magnitude (Baron & Kenny, 1986). 
Research Hypothesis 4b 
Independent variable. Composite score on the knowledge of the 2016 CDC guideline 
(Knowledge)—Ratio level 
Dependent variable. Composite score on the participant’s attitude toward implementing 
the CDC guideline recommendations concerning improved patient outcomes in their 
practice (Attitude)—Ordinal level 
Intervening variable. Composite score on the belief that the 2016 CDC guideline will 
produce improved patient outcomes in relation to CNCP management (Belief)—
Ordinal level 
Statistical tests. Mediation path analysis—Parametric 
To determine whether the intervening variable was acting as a mediator between the 
independent and dependent variables, the researcher performed a path analysis. Figure 5 presents 
a schematic diagram of this path analysis. 
For each of the first six research hypotheses promulgated in this study, an assumption 
about the relationship between a pair of variables was proposed. None of these six hypotheses, 
however, asserts causation between the variables or attempts to say that the value of one variable 
can be used to predict the value of another variable. Therefore, PI used correlational tests—
including Pearson’s r to assess the reasonableness of these hypotheses. 
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CHAPTER IV.  
RESULTS 
This chapter presents the results of the survey and further validates the survey tool for 
construct validity and reliability. 
Sample Characteristics 
The total sample size was 143 primary care practitioners, as demonstrated by post hoc 
power analysis conducted the G*Power. The age range varied from 25 to 69 years of age 
reflecting resident eligible practitioners to semiretired practitioners. The sample revealed age 
groups divided into nine categories. Most participants were in the 35–39 age (n=34, 22% of the 
sample). The age groups of 30–34, 40–44, and 45–49 represented approximately near equal 
percentages of the sample size, 15.72%, 18.87%, and 15.73%, respectively (See Table 3). These 
demographic data indicate that most participants were young early practitioners, and the minority 
of participants fell in the preretirement age category. 
Regarding the CME-training portion of the study, the results indicated most participants 
(43.5%) reported CME completion between 5 and 9 hours in the past 3 years. The next highest 
frequency was 31.5% with 1–4 hours of CME completion. Post licensure training, in relation to 
CME completion, is mandatory for licensure renewal; however, no uniform mandate exists for 
CME dedicated to chronic-pain management. 
For the portion of the demographics relating to highest level of education, the majority of 
participants (102, 64%) of the sample had attained a master’s degree; 31% had obtained a 
professional degree of medical doctorate (MD). The findings indicated that majority of the 
sample comprised midlevel practitioners, as a master’s degree would provide the minimal entry 
to practice.  
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Table 3.  
Participant Demographics  
  Frequency Percent 
Age 25–29 12 7.55 
 30–34 25 15.72 
 35–39 35 22.01 
 40–44 30 18.87 
 45–49 25 15.72 
 50–54 12 7.55 
 55–59 4 2.52 
 60–64 11 6.92 
 65–69 5 3.14 
CME Training 0 hours 5 3.10 
 1–4 hours 50 31.45 
 5–9 hours 66 41.51 
 10–19 hours 38 23.90 
Education Master’s Degree 102 64.15 
 Doctorate Degree (EdD, PhD, PsyD) 8 5.03 
 Professional Degree (MD, DDS) 49 30.82 
Profession Physician 47 29.56 
 Physician Assistant (PA) 57 35.85 
 Nurse Practitioner (NP) 55 34.59 
 
 
 
 
 
 
 
Table 3 Cont.  
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Years of experience 2 10 6.29 
 3 19 11.95 
 4 15 9.43 
 5 17 10.69 
 6 16 10.06 
 7 13 8.18 
 8 9 5.66 
 9 12 7.55 
 10 12 7.55 
 11 4 2.52 
 12 1 0.63 
 13 1 0.63 
 14 2 1.26 
 15 1 0.63 
 18 2 1.26 
 19 3 1.89 
 20 6 3.77 
 22 3 1.89 
 23 2 1.26 
 24 1 0.63 
 26 1 0.63 
 27 2 1.26 
 28 3 1.89 
 30 1 0.63 
 31 1 0.63 
 33 1 0.63 
 37 1 0.63 
Note. N = 143, CME = continuing medical education. 
Exploring the professional status of respondents, participants had a near-equal 
distribution among the three professions practicing primary care. Physicians represented 29.56% 
of the sample, nurse practitioners represented 34.59%, and physician assistants represented 
slightly higher at 35.85%. Participants’ years of experience varied greatly from a minimum of 2 
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years’ experience and a maximum of 37 years. Participants with more than 10 years of 
experience accounted for 30% of the sample. 
Regarding geographic representation of participants, because the PI disseminated this 
survey through Listservs of three national professional organizations, respondents represented a 
wide number of states. The CDC divides geography of the 50 states and the District of Columbia 
into 10 regions, loosely based on Department of Health and Human Services regions. The 
intention was to strengthen the consistency and quality of the guidance, communications, and 
technical assistance provided to states to improve coordination. Each region comprises four to 
seven states. Of the total of 143 responders, the highest number (44, 27.68%) were from the 
southeastern region or Region 4, which includes Alabama, Florida, Georgia, Kentucky, 
Mississippi, North Carolina, South Carolina, and Tennessee. Table 4 provides the regions and 
number of responders from that region. 
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Table 4  
Responses by Region 
Region State N % 
Region 1 Connecticut, Massachusetts, New 
Hampshire, Rhode Island, Vermont 
18 11.31 
Region 2 New Jersey, New York 9 5.66 
Region 3 Delaware, District of Columbia, 
Maryland, Pennsylvania, Virginia, West 
Virginia 
12 7.54 
Region 4 Alabama, Florida, Georgia, Kentucky, 
Mississippi, North Carolina, South 
Carolina, Tennessee 
44 27.68 
Region 5 Illinois, Indiana, Michigan, Minnesota, 
Ohio, Wisconsin 
18 11.32 
Region 6 Arkansas, Louisiana, New Mexico, 
Oklahoma, Texas 
8 5.04 
Region 7 Iowa, Kansas, Missouri, Nebraska 9 5.67 
Region 8 Colorado, Montana, North Dakota, South 
Dakota, Utah, Wyoming 
13 8.18 
Region 9 Arizona, California, Hawaii, Nevada 15 9.43 
Region 10 Alaska, Idaho, Oregon, Washington 12 8.17 
 
Instrument Validation 
Validity of an instrument is the degree to which it measures what it is supposed to 
measure (Field, 2018). The team of authors on the CDC writing committee subjected the 
instruments used in this study to face validity. To further test the construct validity of the 
instrument, the researcher ran factor analysis for the two practice scales, the attitude scale, and 
belief scale (Field, 2018). Factor analysis explores the relationship of multiple observed variables 
have similar patterns of responses because they are all associated with a latent variable (Field, 
2018). Latent variables are variables that researchers do not directly observe but rather infer 
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them from other variables. Factor loading indicate the extent of relevance or relationship of 
variables in explaining a construct. As a rule of thumb, a 0.7 or higher factor loading represents 
that the factor extracts sufficient variance from that variable (Field, 2018). 
The PI ran a series of EFAs with a varimax (orthogonal) rotation and a cut off 1.25 for 
eigenvalue to align with the component. An eigenvalue is a measure of how much of the 
variance of the observed variables the factor explains. For a factor to be considered loading 
cleanly, it needs to have loaded at least .13 higher on a factor. Table 5 displays factor loading 
that could load freely. All but one question located cleanly for the first factor for the belief 
variables. For individual attitudes, several also loaded on the first factor as well as one of the 
second factors and one on the fourth factor. For individual attitudes, several also loaded on the 
first factor as well as one of the second factors and one on the fourth factor. For Practice I (Harm 
Reduction), six items loaded on Factor 2, two items loaded on Factor 3, and one item on Factor 
4. Three questions did not load cleanly on any factor. 
The PI then forced a three-factor solution to see if different results emerged (see Table 6). 
In the forced three-factor solution, the belief scale remained the same with all but one statement 
loading cleanly on Factor 1: Belief Statement 6. All but three individual attitudes loaded cleanly 
on Factor 1; Attitudes Items 6 and 1 loaded on Factor 3, and 9 did not load cleanly at all. Practice 
Statements 1–6 and 16 loaded on Factor 3; Practice Statements 8–15 loaded on Factor 2, and 
Practice Statement 7 did not load cleanly. 
Recognizing that these factors did not load cleanly when all the variables were included 
together, the PI chose to run several different factor analyses to investigate how each scale item 
loaded when they were not with the other scale. The following analysis attempts to examine 
factor loadings separately. 
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Table 5  
Free Loading Exploratory Factor Analysis 
Component 
 1 2 3 4 
Belief 1 0.807 0.388 0.125 -0.064 
Belief 2 0.818 0.373 0.116 -0.007 
Belief 3 0.802 0.402 0.178 0.084 
Belief 4 0.748 0.428 0.181 0.074 
Belief 5 0.709 0.456 0.233 0.105 
Belief 6 0.506 0.523 0.003 0.332 
Individual attitudes 1 0.399 0.357 0.193 -0.342 
Individual attitudes 2 0.804 0.202 0.277 -0.067 
Individual attitudes 3 0.794 0.137 0.369 -0.037 
Individual attitudes 4 0.745 0.012 0.228 -0.250 
Individual attitudes 5 0.742 0.128 0.447 0.052 
Individual attitudes 6 0.405 0.279 0.231 0.593 
Individual attitudes 7 0.722 0.130 0.479 0.047 
Individual attitudes 8 0.711 0.015 0.414 -0.067 
Individual attitudes 9 0.451 0.186 0.544 0.054 
Individual attitudes 10 -0.180 0.153 0.171 0.760 
Practices 1 0.394 0.727 0.262 0.128 
Practices 2 0.379 0.759 0.320 0.127 
Practices 3 0.200 0.781 0.376 0.075 
Practices 4 0.253 0.729 0.440 0.105 
Practices 5 0.168 0.764 0.343 0.176 
Practices 6 0.149 0.688 0.273 0.217 
Practices 7 0.316 0.313 0.339 -0.367 
Practices 8 0.206 0.444 0.611 0.269 
Practices 9 0.280 0.450 0.691 0.113 
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Table 5 continued 
Practices 10 0.298 0.543 0.585 0.175 
Practices 11 0.212 0.484 0.679 0.073 
Practices 12 0.261 0.345 0.685 0.092 
Practices 13 0.212 0.385 0.702 0.109 
Practices 14 0.311 0.139 0.746 0.018 
Practices 15 0.247 0.179 0.673 0.017 
Practices 16 -0.057 0.320 0.104 0.730 
Note. a. Rotation converged in 10 iterations. 
Table 6  
Forced 3-Factor Exploratory Factor Analysis 
 Component 
 1 2 3 
Belief 1 0.848 0.170 0.262 
Belief 2 0.846 0.150 0.289 
Belief 3 0.816 0.203 0.369 
Belief 4 0.768 0.213 0.380 
Belief 5 0.728 0.265 0.419 
Belief 6 0.501 0.027 0.622 
Individual attitudes 1 0.500 0.282 0.043 
Individual attitudes 2 0.816 0.287 0.116 
Individual attitudes 3 0.790 0.363 0.084 
Individual attitudes 4 0.768 0.236 -0.148 
Individual attitudes 5 0.719 0.427 0.133 
Individual attitudes 6 0.313 0.176 0.604 
Individual attitudes 7 0.701 0.460 0.130 
Individual attitudes 8 0.697 0.394 -0.030 
Individual attitudes 9 0.443 0.540 0.168 
Individual attitudes 10 -0.303 0.092 0.609 
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Table 6 Continued    
 1 2 3 
Practice Attitudes 1 0.455 0.345 0.629 
Practice 2 0.444 0.407 0.650 
Practice 3 0.282 0.478 0.626 
Practice 4 0.319 0.527 0.607 
Practice 5 0.230 0.431 0.681 
Practice 6 0.195 0.345 0.653 
Practice 7 0.415 0.423 -0.013 
Practice 8 0.198 0.625 0.496 
Practice 9 0.300 0.724 0.397 
Practice 10 0.321 0.627 0.511 
Practice 11 0.246 0.725 0.394 
Practice 12 0.271 0.704 0.304 
Practice 13 0.225 0.727 0.344 
Practice 14 0.304 0.739 0.100 
Practice 15 0.249 0.676 0.130 
Practice 16 -0.153 0.055 0.719 
Note. a. Rotation converged in 7 iterations. 
Belief Scale 
The PI ran an EFA to explore if all six question items would load on a single factor 
cleanly. The results of the EFA showed Belief did load on a single factor (see Table 7). The total 
variance explained was 70%, which is a strong correlation across variables. The reliability 
statistics of the Cronbach’s alpha coefficient 0.944 signaled a strong correlation across variables. 
A Cronbach’s alpha coefficient of 0.7 or higher signifies high internal consistency. 
EFA Results for Belief. The researcher ran an EFA to test whether all components were 
significant predictors of Belief. As shown in Table 7 Item 6, although still a significant predictor, 
is weaker than the other five variables. An EFA was run with just the five items and, as shown in 
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Figure 6, all items are strong predictors. Therefore, it was decided to eliminate Item 6 and have 
five-item Belief scales, as demonstrated in Table 8. 
 
Table 7.  
EFA With 6 Items in Belief and corresponding Eigen Values 
      Component         B       S.E.       Beta   p 
Belief 1 <--- Belief   0.907 1  0.897  
Belief 2 <--- Belief 0.922 1.013 0.056 0.923 *** 
Belief 3 <--- Belief 0.945 1.102 0.057 0.948 *** 
Belief 4 <--- Belief 0.909 0.956 0.059 0.887 *** 
Belief 5 <--- Belief 0.914 1.044 0.066 0.877 *** 
Belief 6 <--- Belief 0.732 0.841 0.091 0.654 *** 
 
 
Figure 6. Exploratory Factor Analysis with Five Items on the Belief Scale  
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Table 8.  
Exploratory Factor Analysis Standardized Regression Weights: Belief 
   B S.E. Beta p 
Belief 1 <--- Belief 1  0.902  
Belief 2 <--- Belief 1.013 0.055 0.929 *** 
Belief 3 <--- Belief 1.094 0.056 0.947 *** 
Belief 4 <--- Belief 0.947 0.058 0.883 *** 
Belief 5 <--- Belief 1.029 0.066 0.869 *** 
 
Individual Attitudes Scales 
For the Individual Attitude scale, the researcher ran an EFA and found a two-factor 
solution. The PI further explored for the elimination of potential variables to create a better scale. 
The first factor accounted for 54.8% of the variance and the second accounted for 14.3% of the 
variance. For the two-factor loading, the Cronbach’s α = 0.869 signified a very strong 
correlation. In a more detailed examination to improve the scale, a trial removal of Attitudes 
Item 10 resulted in the items converging around a single factor. The researcher constructed the 
Cronbach’s alpha α = 0.909 and thus the variable with just Items 1–9 (see Table 9). 
The PI ran an EFA to see how well the nine items predicted the latent variable of the 
Individual Attitudes Scale. All variables were significant at the p < 0.001 level. Thus, the 
Individual Attitude Scale was constructed with nine items (see Figure 7).  
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Table 9.  
Eigen Values for Items in Individual Attitudes Scale 
 
Component 
1 2 
Individual attitudes 1 0.574 -0.074 
Individual attitudes 2 0.884 0.059 
Individual attitudes 3 0.907 0.087 
Individual attitudes 4 0.810 -0.234 
Individual attitudes 5 0.881 0.170 
Individual attitudes 6 0.418 0.729 
Individual attitudes 7 0.846 0.230 
Individual attitudes 8 0.815 0.037 
Individual attitudes 9 0.663 0.245 
Individual attitudes 10 -0.197 0.873 
Note. N = 143. 
 
Figure 7. Individual Attitude Scale 
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Practice 
The PI ran an EFA to test how Practices aligned. Items loaded on two factors. The first 
accounted for 58.7% of the variance and the second accounted for 8.9% of the variance. Four 
questions did not cleanly load on either. It was decided to break this into two scales, the first with 
Questions 1–11 and 16 (Practice Scale 1), and the second Questions 8–15 (Practice Scale 2). 
After splitting the scales, both scales loaded on a single factor. Practice Scale 1 accounted for 
62% of the variance and had a Cronbach’s α = 0.906. Practice Scale 2 accounted for 68% of the 
variance and had a Cronbach’s α = 0.931 (see Table 10).  
 
Table 10  
Eigen Values for Items in Individual Attitudes Scale 
 1 2 
Practice 1 0.772 0.350 
Practice 2 0.782 0.421 
Practice 3 0.792 0.378 
Practice 4 0.759 0.458 
Practice 5 0.787 0.345 
Practice 6 0.703 0.289 
Practice 7 0.073 0.628 
Practice 8 0.586 0.552 
Practice 9 0.563 0.664 
Practice 10 0.664 0.569 
Practice 11 0.566 0.636 
Practice 12 0.476 0.630 
Practice 13 0.478 0.659 
Practice 14 0.204 0.803 
Practice 15 0.159 0.769 
Practice 16 0.705 -0.226 
Note. N = 143. 
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Practice Scale 1: Harm Reduction. All factors were significant for the Practice Scale 1 
(see Table 11). Figure 8 shows the factor analysis using AMOS software. The circle represents 
the latent variable; rectangles represent measure variables standardized regression (Betas) 
weights indicated on the corresponding arrows, which indicate the strength of factor loading. 
 
Table 11  
Exploratory Factor Analysis Standardized Regression Weights: Practice Scale 1 
   B S.E. Beta p 
Practice 2 <--- PA1 1.084 0.065 0.928 *** 
Practice 3 <--- PA1 1.006 0.065 0.898 *** 
Practice 4 <--- PA1 1.049 0.072 0.869 *** 
Practice 5 <--- PA1 0.909 0.066 0.848 *** 
Practice 6 <--- PA1 0.807 0.08 0.705 *** 
Practice 7 <--- PA1 0.376 0.079 0.387 *** 
Practice 16 <--- PA1 0.402 0.086 0.38 *** 
Practice 1 <--- PA1 1   0.875  
Note. N = 143. 
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Figure 8. Practice Scale I Reduce Harm Exploratory Factor Analysis  
 
Practice Scale 2. All factors were significant for Practice Scale 2 Other Modalities (see 
Table 12). Figure 6 shows factor analysis using analysis of SPSS AMOS software. The circle 
represents latent variables and rectangles represent observable variables standardized regression 
(betas). Weights are indicated with the corresponding arrows, which indicate the strength of 
factor loading (Figure 9). 
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Table 12  
Exploratory Factor Analysis Standardized Regression Weights: Practice Scale 2 
   B S.E. Beta p 
Practice 8 <--- PA2 1  0.797  
Practice 9 <--- PA2 0.961 0.077 0.89 *** 
Practice 10 <--- PA2 0.954 0.078 0.879 *** 
Practice 11 <--- PA2 0.955 0.081 0.854 *** 
Practice 12 <--- PA2 0.889 0.084 0.786 *** 
Practice 13 <--- PA2 0.889 0.082 0.801 *** 
Practice 14 <--- PA2 0.84 0.091 0.712 *** 
Practice 15 <--- PA2 0.666 0.085 0.623 *** 
Note. N = 143. 
 
Figure 9. Practice Scale 2 Other Modalities Exploratory Factor Analysis  
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Descriptive Statistics 
Table 13 represents descriptive statistics for the constructed scales. Practice Scale II scale 
represents efforts to increase use of alternate nonopioid modalities. Ranges for skewness used in 
the analysis were -3 to 3 and ranges for kurtosis were -1 to 1. All scales were normally 
distributed, as neither skewness nor kurtosis was out of range of normal distributions. 
 
Table 13  
Descriptive Statistics Analysis 
 Mean SD Min Max 
Skewness 
-3 to 3 
Kurtosis 
-1 to 1 
Statistic 
Std. 
error Statistic 
Std. 
error 
Knowledge 77.55 12.90 30.00 100.00 -0.83 0.20 0.813 0.403 
Belief Scale 5.20 1.44 1.80 8.40 -0.25 0.20 -0.416 0.403 
Individual 
Attitude Scale 
4.74 0.93 2.11 7.11 -0.42 0.20 0.233 0.403 
Practice 1 
Reduce Harm 
6.35 1.07 3.25 9.00 0.09 0.20 0.192 0.403 
Practice 2 Other 
modalities 
5.33 1.04 3.13 8.63 0.29 0.20 0.225 0.403 
 
Inferential Statistics 
The PI conducted bivariate analysis in SPSS for Research Questions 1–4. 
Years of Experience Impact on Knowledge, Belief, and Attitude 
Research Q 1. What is the relationship between the amount of providers’ years of 
experience and (a) provider’s knowledge of the 2016 CDC Guideline, (b) provider’s 
belief that the 2016 CDC Guideline will reduce the epidemic opioid crisis, and (c) 
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provider’s attitude toward the implementation of the 2016 CDC Guideline will 
produce improved outcomes with regard to CPM? 
H1a: There is a positive relationship between the provider’s years’ experience and the 
provider’s knowledge of the current CDC Guideline. 
A statistically significant bivariate relationship emerged between years of experience and 
knowledge (r = -.217, p = 0.09). As years of experience increased, knowledge decreased (see 
Table 15). 
Table 15 
Bivariate Analysis 
  
CME Knowledge Belief Scale Individual 
Attitude 
Scale 
Practice 1 
Reduce 
Harm 
Practice 2 
Other 
Modalities 
Years of Training r 0.129 -.217** -.657** -.583** -.392** -.375** 
 p  0.126 0.009 0.000 0.000 0.000 0.000 
CME r   .204* 0.075 0.099 .174* 0.148 
 p    0.014 0.372 0.241 0.038 0.078 
Knowledge r     .294** .372** .289** .284** 
 p      0.000 0.000 0.000 0.001 
Belief Scale r       .831** .659** .631** 
 p        0.000 0.000 0.000 
Individual Attitude 
Scale 
r         .620** .700** 
 p          0.000 0.000 
Practice Reduce 
Harm 
r           .789** 
 p            0.000 
Note. CME = continuing medical education. 
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H1b: There is a positive relationship between the provider’s years’ experience and the 
provider’s attitude that that the 2016 CDC guideline will reduce the epidemic opioid 
crisis in relation to CPM. 
A statistically significant relationship emerged between a provider’s years of experience 
and the provider’s attitude that the 2016 CDC Guideline would reduce the epidemic opioid crisis 
in relation to CME (r = -0.657, p < 0.001). As years of experience increased, a provider’s belief 
that the 2016 CDC Guideline would reduce the epidemic opioid crisis decreased. 
H1c: There is a positive relationship between the provider’s years’ experience and the 
provider’s belief that the implementation of the current CDC Guideline will produce 
improved patient outcomes about CPM. 
A statistically significant relationship emerged between a provider’s years of experience 
and the provider’s belief that the implementation of the 2016 CDC Guideline would produce 
improved patient outcomes in CPM (r = -.583, p < 0.001). As years of experience increased, a 
provider’s belief that the implementation of the 2016 CDC guideline would produce improved 
patient outcomes about CPM decreased. 
CME Training Impact on Knowledge, Belief, and Individual Attitude 
Research Question 2. What is the relationship between the amount of provider’s post 
licensure training (CME) in the area of CPM and (a) provider’s knowledge of the 
2016 CDC Guideline, (b) provider’s belief that the 2016 CDC Guideline will reduce 
the epidemic opioid crisis, and (c) provider’s attitude that the implementation of the 
2016 CDC Guideline will produce improved outcomes with regard to CPM? 
H
2a :
There is a positive relationship between the amount of provider’s CME in the area of 
CPM and the provider’s knowledge of the 2016 CDC Guideline. 
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A statistically significant bivariate relationship emerged between a provider’s CME hours 
in CPM and the provider’s knowledge of the 2016 CDC Guideline (r = 0.204, p = 0.059). As a 
provider’s post licensure training hours increased, knowledge of 2016 CDC Guideline increased. 
H
2b
: There is a positive relationship between the amount of provider’s CME in the area of 
CPM and the provider’s belief that that the current CDC Guideline will reduce the 
epidemic opioid crisis in relation to CPM. 
No statistically significant bivariate relationship arose between a provider’s CME hours 
in the area of CPM and the provider’s belief that that the current CDC Guideline would reduce 
the epidemic opioid crisis in relation to CPM (r = .075, p =0 .372). As a provider’s post 
licensure training hours increased, they experienced no change in knowledge of the 2016 CDC 
guidelines. 
H
2c:
 There is a positive relationship between the amount of provider’s CME in the area of 
CPM and the provider’s attitude that the implementation of the current CDC 
Guideline will produce improved patient outcomes. 
No statistically significant relationship arose between the amount of a provider’s CME 
hours in the area of CPM and the provider’s attitude that the implementation of the 2016 CDC 
Guideline would produce improved patient outcomes (r = .099, p > 0.05). As a provider’s post 
licensure training hours increased, no change occurred in the provider’s attitude that the 
implementation would improve patient outcomes. 
Knowledge Impact on Belief and Attitude 
Research Q3. What is the relationship between the provider’s knowledge of the 2016 
CDC Guideline and (a) the provider’s belief that the 2016 CDC Guideline will reduce 
the epidemic opioid crisis in relation to CPM and (b) The provider’s attitude that the 
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implementation of the most current CDC Guideline will produce improved outcomes 
with regard to CPM? 
H2a : There is a positive relationship between the provider’s knowledge of the 2016 CDC 
Guideline and the provider’s belief that the CDC Guideline will reduce the epidemic 
opioid crisis. 
A statistically significant bivariate relationship emerged between knowledge and a 
provider’s belief that the guidelines would reduce the opioid crisis (r = 0.294, p < 0.001). As a 
provider’s knowledge of the guidelines increases, a commensurate increase arose that the 
guidelines would reduce the opioid crisis. 
H2b: There is a positive relationship between the provider’s knowledge of the 2016 CDC 
Guideline and the provider’s attitude that the implementation of the guideline will 
produce improved patient outcomes. 
A significant bivariate relationship emerged between knowledge of the guidelines and 
attitude in that implementation of the guidelines would improve patient outcomes (r = 0.372, p < 
0.001). As provider’s content knowledge of the guidelines increased, the provider’s individual 
attitudes regarding implementation of the guidelines also increased. 
Belief Impact on Individual Attitude 
Research Q 4. What is the relationship between the provider’s belief that the 2016 CDC 
Guideline will reduce the epidemic opioid crisis in relation to CPM and the provider’s 
attitude of the implementation of the CDC Guideline will produce improved 
outcomes with regard to CPM? 
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H3: There is a positive relationship between the provider’s belief that the CDC Guideline 
will reduce the epidemic opioid crisis and provider’s attitude that the implementation 
of the 2016 guidelines will produce improved outcomes about CPM. 
A statistically significant bivariate relationship emerged between belief and individual 
attitude (r = 0.831, p < 0.001). Aligned with an increase on the belief scale, a provider’s 
individual attitude scale score increased regarding implementation of the guidelines to improve 
patient outcomes. 
Path Analysis 
Structural equation modeling is a statistical analysis method that uses a multivariate 
approach to analyze structural relationships. Structural equation modeling includes factor 
analysis and multiple regression analysis, incorporating measured variables and latent constructs. 
Knowledge—Belief- Practice 
Research Q 5. Do either of the following variables act as mediators between the 
provider’s knowledge of the 2016 CDC Guideline and the provider’s attitude 
regarding the implementation of the 2016 CDC Guideline in their own practice? 
a) The provider’s belief that the 2016 CDC Guideline will reduce the epidemic 
opioid crisis in relation to CPM. 
b) The provider’s belief that the implementation of the 2016 CDC Guideline will 
produce improved patient outcomes with regard to CPM. 
H4a The provider’s belief that the 2016 CDC Guideline will reduce the epidemic opioid 
crisis in relation to CPM acts as a mediator between the provider’s knowledge of the 
2016 CDC Guideline and the provider’s attitude regarding the implementation of the 
2016 CDC Guideline recommendations in their own practice. 
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Knowledge—IA-Practice 
H4b The provider’s belief that the implementation of the 2016 CDC Guideline will 
produce improved patient outcomes in CPM acts as a mediator between a provider’s 
knowledge of the 2016 CDC Guideline and the provider’s attitude regarding the 
implementation of the 2016 CDC Guideline recommendations in their own practice. 
The proposed model in the methodology section included all the main variables plus 
practice years, CME, and doctor or physician assistant. After running the proposed model, I 
discovered that goodness of fit results did not align with a good fit model. I reevaluated the 
model to make the model stronger. The results of this initial run appear in Table 14. 
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Table 14  
Path Results 
   B S.E. Beta p 
Knowledge <--- Training -0.369 0.139 -0.217 .008 
Belief Scale <--- Knowledge 0.018 0.007 0.159 .012 
IA Scale <--- Knowledge 0.019 0.005 0.258 *** 
IA Scale <--- Training -0.064 0.008 -0.527 *** 
Belief Scale <--- Training -0.118 0.012 -0.623 *** 
Harm <--- Knowledge 0.005 0.005 0.06 .374 
Modalities <--- Knowledge 0.001 0.005 0.014 .831 
Harm <--- Belief Scale 0.343 0.082 0.473 *** 
Modalities <--- IA Scale 0.621 0.123 0.558 *** 
Modalities <--- Belief Scale 0.111 0.078 0.155 .153 
Harm <--- IA Scale 0.206 0.131 0.183 .115 
Harm <--- CME 0.138 0.082 0.107 .091 
Modalities <--- CME 0.103 0.077 0.081 .179 
Harm <--- Doctor -0.115 0.166 -0.051 .489 
Modalities <--- Doctor -0.006 0.157 -0.003 .968 
Harm <--- PA -0.038 0.157 -0.017 .809 
Modalities <--- PA 0.071 0.148 0.033 .634 
Note. IA = Individual Attitude, CME = continuing medical education, PA = physician assistant. 
To improve the model, the following steps were performed based on the suggestions from 
AMOS about improving the model: Using the modification indices, the researcher connected 
Error 1 (e1) to Error 4 (e4) and ran the model again. Goodness of fit results were still 
unsatisfactory, such that X2 was 177.78, p < 0.001, root mean square error of approximation 
(RMSEA) was 0.363, and confirmatory fit index (CFI) was 0.720. Modification indices also 
indicated that elimination of the nonsignificant variables might the improve overall fit. 
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The model had several nonsignificant variables. A stepwise approach to eliminating 
nonsignificant variables of physician assistants, doctor, and CME impacted the model fit. Model 
statistics resulted in X2 (2) = 1.948, p = 0.378, RMSEA = .00. This outcome might be explained 
due to the X2 being less than the degrees of freedom in the model, which is 2. Any further 
manipulation in the model would yield a significant X2 and an RMSEA would have a high value. 
Therefore, this was the best model achievable. 
Direct Results 
Knowledge was a significant predictor of the Belief Scale, Beta = 0.16, p = 0.002. As the 
knowledge variable increased, the belief variable also increased. Knowledge was a significant 
predictor of the individual attitude scale, Beta = 0.26, p < 0.001. As knowledge increased, scores 
on the individual attitude scale increased. Knowledge did not directly predict either of the 
practice variables (Practice Scale I or Practice Scale II). 
Belief was a significant predictor of Practice Scale I (harm reduction), Beta = 0.47, p < 
0.001. As a provider’s belief increased, their Practice Scale (harm reduction) increased. 
However, belief was not a predictor for Practice Scale II (using nonopioid modalities). Individual 
attitude was a significant predictor of harm reduction, Beta = 0.20, p = 0.008. As individual 
attitude increased, practicing attitudes of harm reduction also increased. 
Individual attitudes were a significant predictor of Practice Scale in using nonopioid 
modalities, Beta = 0.56, p < 0.001. As individual attitude increased, a provider’s practice of 
using nonopioid modalities also increased. Knowledge effects were completely mediating 
through individual attitude and belief. This makes a clear illustration that knowledge alone does 
not signal practice behavior. The subjective construct of belief and respective attitude influence 
the manner which provider practices. This may have impact on rejection or acceptance of given 
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knowledge and consequent utilization of guidelines. As practitioners are individuals with strong 
beliefs and personal experiences, they represent positive or negative attitudes despite learned 
knowledge which impact practice. Indirect effect on harm was Beta = 0.126 and its indirect 
effects on Modalities was Beta = 0.169. See Table 15 and Figure 10. 
 
Table 15  
Received Path Model Direct Results 
DV  IV B S.E. Beta p 
Belief Scale <--- Knowledge 0.018 0.007 0.159 .012 
Belief Scale <--- Training -0.118 0.012 -0.623 *** 
Harm <--- Knowledge 0.006 0.006 0.076 .252 
Harm <--- 
Belief 
Scale 
0.347 0.083 0.469 *** 
Harm <--- IA Scale 0.232 0.132 0.201 .08 
IA Scale <--- Knowledge 0.019 0.005 0.258 *** 
IA Scale <--- Training -0.064 0.008 -0.527 *** 
Knowledge <--- Training -0.369 0.139 -0.217 .008 
Modalities <--- Knowledge 0.002 0.005 0.03 .641 
Modalities <--- IA Scale 0.626 0.124 0.556 *** 
Modalities <--- 
Belief 
Scale 
0.116 0.078 0.16 .135 
Note. DV = dependent variable, IV = independent variable, IA = Individual Attitude. 
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Figure 10. Final Path Model 
Statistical Analysis for Each Quantitative Research Question 
 
Summary 
 Table 16 presents a summary of findings for this project. Of the 11-hypothesis given, 
only four were found lead to a failure to reject the null hypothesis.  
Table 16.  
Summary of Hypothesis Testing 
 Reject Fail to 
Reject 
H1a :There is no statistically significant relationship between the amount 
of provider’s post-licensure training in the area of CPM and the 
provider’s knowledge of the 2016 CDC Guideline. 
X 
 
H1b: There is no statistically significant relationship between the amount 
of provider’s post-licensure training in the area of CPM and the 
provider’s belief that that the 2016 CDC Guideline will reduce the 
epidemic opioid crisis in relation to CPM. 
 X 
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H1c: There is no statistically significant relationship between the amount 
of provider’s post-licensure training in the area of CPM and the 
provider’s belief that the implementation of the 2016 CDC Guideline 
will produce improved outcomes in CPM.  
 X 
H2a: There is no statistically significant relationship between the amount of 
provider’s years’ experience and provider’s knowledge of the 2016 CDC 
Guideline. 
X  
H2b: There is no statistically significant relationship between the amount 
of provider’s years’ experience and the provider’s individual attitude hat 
that the 2016 CDC Guideline will reduce the epidemic opioid crisis in 
relation to chronic pain management. 
X  
H2c: There is no statistically significant relationship between the amount 
of provider’s years’ experience and  the provider’s belief that the 
implementation of the 2016 CDC Guideline will produce improved 
outcomes in the area of CPM.  
X  
H3a:  There is no statistically significant relationship between the 
provider’s knowledge of the 2016 CDC guidelines and the provider’s 
belief that that the CDC Guidelines will reduce the epidemic opioid 
crisis in relation to CPM. 
X  
H3b: There is no statistically significant relationship between the 
provider’s knowledge of the 2016 CDC Guidelines and the provider’s 
belief that the implementation of the2016 CDC Guideline will produce 
improved outcomes in CPM. 
X  
H4: There is no statistically significant relationship between the 
provider’s belief that the 2016 CDC Guideline will reduce the epidemic 
opioid crisis in relation to CPM and the provider’s belief that the 
implementation of the 2016 CDC Guideline will produce improved 
outcomes. 
X  
H5a:   The provider’s belief that the 2016 CDC Guideline will reduce the 
epidemic opioid crisis in relation to CPM acts as a mediator between the 
provider’s knowledge of the 2016 CDC Guideline and the provider’s 
attitude regarding the implementation of the 2016 CDC Guideline 
recommendations in his or her own practice. 
 X 
H5b:  The provider’s belief that the implementation of the 2016 CDC 
Guideline will produce improved patient outcomes in CMP acts as a 
mediator between the provider’s knowledge of the 2016 CDC Guideline 
and the provider’s attitude regarding the implementation of the 2016 
CDC Guideline recommendations in his or her own practice. 
 X 
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CHAPTER V 
DISCUSSION, CONCLUSIONS, AND RECOMMENDATIONS 
Discussion 
The CDC released the Guideline for Prescribing Opioids for Chronic Pain in 2016. The 
CDC Guideline recommendations revealed much confusion and resistance from patient-
advocacy groups and medical providers. To date, the guidelines remain unrevised and few peer-
reviewed publications describe factors that impede the engagement of primary care providers in 
fully using these guidelines. The purpose of this analysis was to assess foundational constructs of 
knowledge, beliefs, and attitudes in the CDC opioid prescribing guidelines. Understanding 
perspectives from a primary care provider lens may help demystify the hesitancy in 
incorporating the guidelines in their respective practices. 
Key Findings 
CME Training Impact on Knowledge, Belief, and Individual Attitude 
This study assessed the relationship between primary care providers’ knowledge, beliefs, 
attitudes, and practices with specific recommendations made by CDC’s 2016 opioid prescribing 
clinical guidelines. It would be logical to expect a strong positive correlation between these 
variables and practice behaviors. However, not all variables proved to have a positive impact on 
outcome variables of practice. Davis and Taylor-Vaisey (1997) concluded CME activities are the 
basis on which gains in knowledge lead physicians to improve their practices and thereby deliver 
improved patient outcomes. However, majority of physicians failed to embrace the guidelines, 
leaving a gap between the reality of practice and the ideal practice. Study findings similarly 
showed a statistically significant positive bivariate relationship between providers’ CME hours 
in the area of CPM and providers’ knowledge of the 2016 CDC Guideline (r = .204, p < 0.014). 
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However, the correlation is a weak one, signaling a lesser likelihood of adherence to 2016 CDC 
Guideline for opioid prescribing. Study results also showed no statistically significant 
relationship between provider’s CME hours in area of CPM and the provider’s belief that the 
current CDC Guideline will reduce the epidemic opioid crisis in relation to CPM (r = 0.075, p > 
0.05). As belief constructs closely interlink with attitude constructs, this study also showed 
consistently that no statistically significant relationship exists between the number of a 
provider’s CME hours in the area of CPM and the provider’s attitude that the implementation of 
the 2016 CDC Guideline would produce improved patient outcomes (r = 0.099, p > 0.05). 
This study did not differentiate between specific guidelines relating to opioid 
management and other types of CME relating to generic pain management. To date, only two 
states require sizable CME hours specific to opioid prescribing—California and Kentucky (12 
credit hours)—but the remaining states have minimal to no required hours relating to opioid 
prescribing guidelines. In this study, 61 of 143 participants, or 43%, reported 5–9 hours of CME 
achieved in the past 3 years. Another 31 (22%) of participants reported 10–19 hours of CME 
completed in the past 3 years. Last, only 5, or 3.5%, of participants reported minimal continuing 
medical education in CPM. It is plausible that study participants conflated the answer of CME 
hours with other CMEs not specific to opioid prescribing. 
McMalmot’s (2018) study divided the sample into three CME groups: minimal (0–3) 
hours, moderate (4–10) hours, and high (≥ 11) CME hours of training. The three CME groups 
aligned increased use of CDC opioid recommended practices (29.4, 34.2, 38.8, respectively; p = 
0.001; scale 0–50) and confidence in pain management (5.5, 5.9, 6.9, respectively; p < 0.001, 
scale 0–9). McMalmot concluded higher hours of continuing education positively impacted a 
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provider’s confidence in pain management use of the CDC Guideline. I did not analyze the 
variable of provider confidence in this study. 
Years of Experience Impact on Knowledge, Belief, and Attitude 
Limited literature examined a correlation between years of experience in practice and 
practice outcomes. Benner (1984) defined experience as time in practice and self-reflection that 
allows past leanings to be refined in real-time circumstances. Dryefus and Dryefus (1980) 
developed the concept of a novice with less than 3 years’ experience, thereafter, rising to an 
expert status with greater than 10 years of experience. The team elaborated that novice 
professionals rely highly on rules and guidelines and as they mature to the level of expert, adhere 
less to regimented rules and make more intuition-based decisions. This paradigm applied to the 
medical profession would suggest that increased years in clinical experience should enhance 
knowledge and thus clinical outcomes. Choudhry et al. (2005) conducted a meta-analysis of 62 
empirical studies investigating the relationship between clinical experience and performance. 
The study reported 32 of 62 (52%) evaluations showed decreasing performance with increasing 
years in practice for all outcomes assessed. The researchers concluded that physicians with 
greater years in practice and older physicians have less factual knowledge and were less likely to 
adhere to standards of care or adopt newer guidelines. Similarly, this study showed a statistically 
significant negative bivariate relationship between years of experience and knowledge                      
(r = -0.217, p < 0.05). This inverse relationship means as medical practitioners have increased 
years of experience, they have decreased knowledge of the 2016 CDC opioid practice guidelines. 
Additionally, a statistically significant negative relationship emerged between a 
provider’s years of experience and the provider’s belief that the 2016 CDC Guideline would 
reduce the epidemic opioid crisis in relation to CPM (r = -0.657, p < 0.001). Last, a statistically 
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significant negative relationship emerged between a provider’s years of experience and the 
provider’s attitude that the implementation of the 2016 CDC Guideline would produce improved 
patient outcomes in CPM (r = -0.583, p < 0.001). 
Unlike in physics and chemistry, medicine is a dynamic applied science. Like any 
dynamic process, it requires learning, growth, and adaptation. Although years of experience is a 
highly regarded and respected attribute, it should not discourage new learning and engagement in 
current trends in quality measures to improve practice. 
Knowledge Impact on Belief and Attitude 
Knowledge is understanding or comprehension of information or facts through education. 
Knowledge is regarded as an objective and cognitive construct (Pajares & Thompson, 1992). 
Belief is a more subjective, experience-based, often implicit construct. Often, belief is affective 
in nature (Thompson, 1992). More strongly held beliefs are more central, and weaker beliefs are 
more “peripheral” (Green, 1971). The more central or the stronger a belief, the less it is 
susceptible to change and thus impacts attitudinal behaviors. This study addressed the 
relationship between a provider’s knowledge of the 2016 CDC Guideline and the provider’s 
belief that the 2016 CDC Guideline would reduce the epidemic opioid crisis in relation to CPM 
and, by extension, the provider’s attitude that the implementation of the 2016 CDC Guideline 
would produce improved outcomes regarding CPM. The analysis revealed a statistically 
significant positive bivariate relationship between knowledge and a provider’s belief that the 
guidelines would reduce the opioid crisis (r = 0.294, p < 0.001). Thus, as knowledge scores 
increased, a corresponding increase arose in the belief variable that the guidelines would 
positively impact the opioid crisis by reducing the epidemic. Additionally, a statistically 
significant positive relationship emerged between knowledge of the guidelines and attitude that 
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implementation of the guidelines will improve patient outcomes (r = 0.372, p < 0.001). It follows 
that a strong or centrally held belief will have an equally strong parallel impact on attitudinal 
constructs and, in this case, attitude that the use of the guidelines would improve each individual 
patient’s outcome. 
No comparative study in the literature examined knowledge and its impact on belief that 
guidelines would influence the reduction of the opioid epidemic, nor did any study investigate 
attitudinal impact between knowledge and improved patient outcomes. In a prospective 
longitudinal study, Jamison et al. (2014) surveyed 56 primary care practitioners on their beliefs 
and attitudes about opioid prescribing and CPM and concluded that younger providers were less 
knowledgeable about opioids, but opioid knowledge did not relate to concerns about opioid 
prescription practices. The Jamison et al. study predated the 2016 CDC opioid prescribing 
guidelines and was limited to a small sample size. Pearson et al. (2017) investigated provider 
confidence levels in prescribing opioids to noncancer patients. Providers in that study (60.8%) 
were not confident of their ability to manage chronic pain and their levels of confidence 1 year 
after targeted intervention did not significantly improve (44.7%, p > 0.05). Many primary care 
providers continued to lack confidence in managing pain patients and reported reluctance to 
prescribe opioids for CNCP. This study supports knowledge impact on Practice Scales, as the 
providers’ belief of confidence decreases their attitude toward prescribing practice decreases 
despite increase in infused knowledge of intervention. 
In examining the relationship between a provider’s belief that the 2016 CDC Guideline 
would reduce the epidemic opioid crisis and a provider’s attitude on the implementation of the 
CDC Guideline would produce improved patient outcomes, this study revealed a statistically 
strong significant and positive bivariate relationship between belief and individual attitude on 
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improved patient outcomes (r = 0.831, p < 0.001). As an increase arose in the belief scale, an 
increase arose on the individual attitude scale regarding using the guidelines to improve patient 
outcomes. As discussed earlier, the stronger a belief, the more the believer is resistant to change, 
impacting the provider’s attitudinal behaviors. 
Mediating Variables 
Path analysis is a form of multiple regression statistical analysis that researchers use to 
evaluate causal models by examining relationships between a dependent variable and two or 
more independent variables. In this study, the PI found that belief has a mediating effect between 
knowledge of the guidelines and providers’ Practice Scales. A provider’s belief that the 2016 
CDC Guideline would reduce the epidemic opioid crisis in CPM acted as a mediator between the 
provider’s knowledge of the 2016 CDC Guideline and the provider’s attitude regarding the 
implementation of the 2016 CDC Guideline in their own practice. The provider’s belief that the 
implementation of the 2016 CDC Guideline would improve outcomes of patients with CPM acts 
as a mediator between the provider’s knowledge of the 2016 CDC Guideline and the provider’s 
attitude regarding the implementation of the 2016 CDC Guideline in their own practice. 
Therefore, the researcher failed to reject the null hypothesis because it hypothesized that 
knowledge impacts on practice would be mediated by individual attitude and belief, supported by 
path analysis. Last, although belief clearly mediated between knowledge and practice, attitude 
did not mediate practice. This outcome leads to a thought-provoking conundrum that may lead to 
exploration of granularity in attitudes in future studies. 
Limitations of the Study 
As with majority of studies, the design of the current study is subject to limitations. 
The following are major limitations of this study that could be addressed in future research. 
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1. Due to the contemporary nature of this study, exploring novel guidelines on opioid 
prescribing, from a review of the literature, limited published research described 
practitioner perspectives on the subject. Thus, the ability to identify a gap in the 
literature and develop research questions was challenging. 
2. This study focused on self-reported data on the 2016 publication of the CDC 
Guideline for opioid prescribing. Self-reported data rarely can be independently 
verified (Price & Murnan 2004). The data collection was completed in its entirety in 
2019; thus, respondents may have had diminished recall of the specific guidelines or 
may have been confused with more recent guidelines, such as state guidelines, 
organizational guidelines, or even standards of care. Additionally, the measurement 
of practice variable was not defined with standardized protocol. That is self-reported 
practice variable may or may not reflect a gold standard, as uniformity among 
practice is variable.    
3. The sample was not randomized. A convenience sample is an inexpensive way to 
ensure sufficient number for nonprobability samples; therefore, the population may 
have been underrepresented (Portney & Watkins, 2009). 
4. The study was conducted through a web-based online survey to ensure anonymity and 
confidentiality. However, it is unknown how many members may have missed 
capture due to limited to access to email or the internet. 
5. The study design was limited to quantitative methods. Although using Likert-type 
scales can provide an idea about how strongly a participant feels about a statement, 
this study did not include a qualitative portion, where open-ended or leading 
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questions might provide more in-depth responses, reflecting participants’ actual 
feelings rather than being restricted by categories. 
 
6. The design of this study was cross-sectional and, as a result, it was not possible to 
determine causality. A longitudinal approach would provide more comprehensive 
understanding of the subject matter and the corresponding relationship. However, due 
to time constraints, this was not possible. 
7. Selection bias: The data accrued from three professional organizations: American 
Association of Nurse Practitioners, the American Association of Physician Assistants, 
and the Academy of Family Practice Physicians. Organizational membership is not a 
mandatory practice requirement. Therefore, the results or findings from this study 
may not be generalized to practitioners who have chosen not to maintain active 
membership to their prospective organization. 
Clinical Relevance 
Pain is a complex phenomenon and thus the problem has no single solution. General 
practitioners have minimal preparation to manage complex pain-related issues without 
appropriate guidelines. The limited number of specialists trained to manage challenging pain 
patients places a great level of stress on primary care providers. A need exists for uniformity and 
standardization in opioid prescribing practices. It is equally important that guidelines are in 
alignment at the federal, state, and organizational levels. Overprescribing opioids has partly 
contributed to opioid-related overdoses and fatalities. CDC’s mission to protect public health 
places this authoritative body at the highest persuasive position to develop guidelines for 
prescribing opioids. It is not sufficient for providers to become familiar with the 2016 CDC 
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opioid-prescribing guidelines; they must retain the critical knowledge of the guidelines and use 
the guidelines routinely. State boards of licensing should consider formal learning modules and 
certificates of attestation for those with passing knowledge scores. Such learning modules could 
be considered a prerequisite to obtaining and renewing Drug Enforcement Administration 
registration. Physicians, as lead patient-safety advocates, should champion adoption of 
prescribing guidelines and thus lead the movement for safe prescribing practices for their 
colleagues and midlevel providers. 
Future Research 
Although this study adds to the existing body of knowledge regarding the 2016 CDC 
Guideline relating to opioid prescribing for primary care providers, it also generates several 
research questions to be explored for future research. The PI did not address characteristics of 
clinical guidelines in this study. Other researchers documented that guidelines inherently 
accompany barriers such as ease of use, trialability, and complexity (Cabana et al., 1999); these 
barriers are known reasons for guideline adoption and compliance. Incorporating guideline 
characteristics into the survey tool may also enhance study results and may further highlight 
concerns from providers who adopt or reject clinical practice guidelines relating to opioid 
prescribing practices. Moreover, future researchers can expand exploration of practitioner 
characteristics of time, resources, or organizational support as well as constraints. 
Although this study found no statistical difference in practitioner type and the 
implementation of clinical guidelines; it may be prudent to study midlevel populations separately 
to gain a better understanding of midlevel practices that may be untethered by scope-of-practice 
restrictions. The knowledge component showed low knowledge scores on the 2016 CDC 
guidelines; it would be revealing to further explore practitioner type and knowledge. For 
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example, is there a difference in knowledge of midlevel practitioners engaged in urban practice 
areas or areas of high opioid use versus midlevel practitioners in suburban or rural practice 
settings. The sample for this study was sourced through membership in professional 
organizations; expanding sample eligibility through recruitment of licensure boards may improve 
generalizability of the results. Lastly, adding a qualitative portion to the survey tool may provide 
more insightful understanding of participants’ hesitation in embracing 2016 CDC opioid 
prescribing guidelines. 
Conclusion 
This study provides useful insights into factors that influence primary care clinician 
intentions to adopt opioid prescription practices for chronic pain patients. Addressing factors 
such as knowledge, attitudes, and beliefs can assist in encouraging implementation strategies to 
positively affect primary care practitioners’ prescriptive behaviors. In this study, knowledge was 
a significant predictor of belief and attitude regarding the value of 2016 CDC opioid prescribing 
guidelines. However, increased knowledge did not directly predict practice intention to use the 
guidelines to reduce patient harm or use nonopioid practices, as recommended by the guidelines. 
Increased CME hours was a significant predictor of knowledge scores, belief, and attitudes. This 
outcome suggests that to influence the practice of primary care physicians, it would be useful to 
provide more educational activities and frequent reinforcement. In examining mediating 
variables, knowledge effects were completely mediated by attitudes and beliefs. Future 
investigation into the affective factors that influence motivation to integrate current practice 
guidelines may demystify the reasons for resistance to guideline adoption. 
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Letter of solicitation and Implied Consent 
 
Dear Colleague, 
 
My name is Maria Adamian. I would like to invite you to participate in a research study                  
(Medical providers’ Knowledge and Belief in the Effectiveness of the Centers for Disease 
Control and Prevention’s 2016 Guideline for Prescribing Opioids for Chronic Pain).  I am a 
doctoral student at the department of Interprofessional Health Sciences and Health 
Administration, in the School of Health and Medical Sciences, Seton Hall University.  I am 
conducting this research as partial fulfillment of my PhD degree in Health Sciences. 
 
What is the purpose of the study? 
 
This study will explore Medical Providers’ Knowledge and Belief in the Effectiveness of the 
Centers for Disease Control and Prevention’s 2016 Guideline for Prescribing Opioids for 
Chronic Pain. In the climate of opioid crisis and escalated public health threat of increasing 
opioid related mortality, this timely study will investigate factors that may influence 
practitioners’ attitudes towards prescribing guidelines from federal agency. The factors that will 
be explored are knowledge, attitude among primary care practitioners and their relationship to 
daily practices. 
 
Is participation voluntary? 
 
Your participation in this study is entirely voluntary and anonymous. You may withdraw from 
the study at any time without any penalty.  
 
Clicking on the link below signifies your consent to participate in this study. 
 
https://www.surveymonkey.com/r/TGJZXHJ. 
 
How will the study date be handled? 
 
All data from this study will remain confidential. All data will be stored in password protected 
USB memory stick locked in a physical secure box. No other personnel will have access to the 
USB content, and no data will be available electronically. 
 
Is there any risk or any benefits to partaking in the study? 
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There is no risk in completing the study questionnaire. 
There is no direct benefit to the participant in completing the study. However, the results will 
provide enlightenment relating to provider intention to adopt 2016 CDC opioid prescribing 
guidelines.  
 
 
Is there compensation for participation? 
 
There is no compensation for participation in the research study. 
 
What is the expected time commitment to complete the study? 
 
An anticipated 15-20 minutes to complete the study. 
How can I learn more information on the study? 
As principal investigator, I may be contacted at any time for further discussion relating to the 
study at Maria.Adamian@Shu.edu or (201)249-4151. Additionally, you may contact Seton Hall 
IRB at email irb@shu.edu or phone (973) 313-6314. 
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